Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
AIDS
    March 2021

  1. A multilevel intervention to reduce stigma among alcohol consuming men living with HIV receiving antiretroviral therapy: findings from a randomized control trial in India: Erratum.
    AIDS. 2021;35:527.
    >> Share

  2. LUO G, Su L, Hu X, Lin YF, et al
    The role of e-commerce platforms in optimizing the HIV care continuum.
    AIDS. 2021;35:521-522.
    >> Share

  3. VANCE DE, Brew BJ
    HIV neurocognitive impairment and Alzheimer's disease: sniffing out the difference.
    AIDS. 2021;35:511-513.
    >> Share

    February 2021
  4. FALADE-NWULIA O, Seaberg EC, Snider AE, Rinaldo CR, et al
    Outcomes of acute hepatitis B virus (HBV) in HIV infection with and without HBV-active antiretroviral therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96487.
    >> Share

  5. HAYS AG, Schar M, Barditch-Crovo P, Bagchi S, et al
    A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96486.
    >> Share

  6. HOLT M, Broady TR, Mao L, Chan C, et al
    Increasing pre-exposure prophylaxis use and 'net prevention coverage' in behavioural surveillance of Australian gay and bisexual men, 2014-19.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96485.
    >> Share

  7. KIMMEL SD, Walley AY, Lodi S, Forman LS, et al
    Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96484.
    >> Share

  8. HATCHER AM, Brittain K, Phillips TK, Zerbe A, et al
    Longitudinal association between intimate partner violence and viral suppression during pregnancy and postpartum in South African women.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96483.
    >> Share

  9. NELSON M, Winston A, Hill A, Mngqibisa R, et al
    Efficacy, safety and CNS effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine in a randomized controlled trial.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96482.
    >> Share

  10. MOODLEY Y, Tomita A, de Oliveira T, Tanser F, et al
    HIV viral load and pregnancy loss: Results from a population-based cohort study in rural KwaZulu-Natal, South Africa.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96481.
    >> Share

  11. SHIAU S, Brummel SS, Kennedy EM, Hermetz K, et al
    Longitudinal changes in epigenetic age in youth with perinatally-acquired HIV and youth who are perinatally HIV-exposed uninfected.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96480.
    >> Share

  12. EKENBERG C, Reekie J, Zucco AG, Murray DD, et al
    The association of HLA alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96479.
    >> Share

  13. YANG FN, Bronshteyn M, Flowers SA, Dawson M, et al
    Low CD4 nadir exacerbates the impacts of APOE epsilon4 on functional connectivity and memory in adults with HIV.
    AIDS. 2021 Feb 5. pii: 00002030-900000000-96491.
    >> Share

  14. MELLOR MM, Bast AC, Jones NR, Roberts NW, et al
    Risk of adverse COVID-19 outcomes for people living with HIV: a rapid review and meta-analysis.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96494.
    >> Share

  15. ZOU W, Xing J, Wang F, Chen X, et al
    HIV-1LAI Nef blocks the development of hematopoietic stem/ progenitor cells into T lymphoid cells.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96493.
    >> Share

  16. ROTHAN C, Yero A, Shi T, Farnos O, et al
    ART-treated HIV-infected adults with coronary artery disease are characterized by a distinctive regulatory T-cell signature.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96492.
    >> Share

  17. HAMZAH L, Post FA
    Effect of menopause on weight gain, insulin and waist circumference in women with HIV who switch antiretroviral therapy to abacavir/lamivudine/dolutegravir.
    AIDS. 2021;35:349-351.
    >> Share

  18. ROTHERAM-BORUS MJ, Wynn A, Stewart J, Almirol E, et al
    Outcomes of HIV-exposed but uninfected children in South Africa over 5 years.
    AIDS. 2021;35:347-349.
    >> Share

  19. JOSEPH DAVEY DL, de Villiers L, Evens E
    Importance of rigorous implementation science studies to scale-up evidence-based interventions to end the HIV epidemic in the United States.
    AIDS. 2021;35:335-336.
    >> Share

  20. MOYO F, Mazanderani AH, Murray T, Sherman GG, et al
    Achieving maternal viral load suppression for elimination of mother-to-child transmission of HIV in South Africa.
    AIDS. 2021;35:307-316.
    >> Share

  21. SALVATORE PP, de Broucker G, Vojnov L, Moss WJ, et al
    Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries.
    AIDS. 2021;35:287-297.
    >> Share

  22. MCENTIRE CRS, Fong KT, Jia DT, Cooper ER, et al
    Central nervous system disease with JC virus infection in adults with congenital HIV.
    AIDS. 2021;35:235-244.
    >> Share

  23. ANDERSSON E, Ambikan A, Brannstrom J, Aralaguppe SG, et al
    High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden.
    AIDS. 2021;35:227-234.
    >> Share

  24. CAZZANIGA A, Scrimieri R, Galli M, Maier J, et al
    Unveiling the basis of antiretroviral therapy-induced osteopenia: the effects of Dolutegravir, Darunavir and Atazanavir on osteogenesis.
    AIDS. 2021;35:213-218.
    >> Share

    January 2021
  25. WANG L, Moqueet N, Simkin A, Knight J, et al
    Mathematical modelling of the influence of serosorting on the population-level HIV transmission impact of pre-exposure prophylaxis.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96503.
    >> Share

  26. MADEDDU G, De Vito A, Cozzi-Lepri A, Cingolani A, et al
    Time spent with viral load
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96502.
    >> Share

  27. OLIVEIRA NL, Kennedy EH, Tibshirani R, Levine A, et al
    Longitudinal 5-year prediction of cognitive impairment among men with HIV disease.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96501.
    >> Share

  28. MUCCINI C, Galli L, Poli A, Godino C, et al
    Exercise ECG for coronary artery disease screening in people living with HIV: The cordis STUDY.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96500.
    >> Share

  29. GEBREBRHAN H, Kambaran C, Sivro A, Adhiambo W, et al
    Rectal microbiota diversity in Kenyan men who have sex with men (MSM) is inversely associated with frequency of receptive anal sex, independent of HIV status.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96499.
    >> Share

  30. CHAN P, Kerr SJ, Kroon E, Colby D, et al
    Cognitive trajectories after treatment in acute HIV infection.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96498.
    >> Share

  31. NYAKATO P, Schomaker M, Sipambo N, Technau KG, et al
    Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa.
    AIDS. 2021 Jan 21. pii: 00002030-900000000-96504.
    >> Share

  32. ARANTES I, Bello G, Darcissac E, Lacoste V, et al
    Using phylogenetic surveillance and epidemiological data to understand the HIV-1 transmission dynamics in French Guiana.
    AIDS. 2021 Jan 18. pii: 00002030-900000000-96506.
    >> Share

  33. JOHNSTON PI, Wright SW, Orr M, Pearce FA, et al
    Worldwide relative smoking prevalence among people living with and without HIV: a systematic review and meta-analysis.
    AIDS. 2021 Jan 18. pii: 00002030-900000000-96505.
    >> Share

  34. BYONANEBYE DM
    Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents.
    AIDS. 2021 Jan 13. pii: 00002030-900000000-96508.
    >> Share

  35. KANG R, Li J, Chen H, Tang Z, et al
    Using longitudinal genetic-network study to understand HIV treatment-as-prevention: a population-based observational study.
    AIDS. 2021 Jan 13. pii: 00002030-900000000-96507.
    >> Share

  36. LIU FF, Hall V, Cronin KM, Nair AP, et al
    'Peeling back the onion layers': the challenge of HIV-associated multicentric Castleman's disease.

    AIDS. 2021;35:159-161.
    >> Share

  37. ASHOK A, Hoy J, Spelman D, McMahon J, et al
    Successful treatment of disseminated Mycobacterium simiae infection in a patient with advanced HIV.
    AIDS. 2021;35:157-158.
    >> Share

  38. TRAEGER MW, Patel P, Guy R, Hellard ME, et al
    Changes in HIV preexposure prophylaxis prescribing in Australian clinical services following COVID-19 restrictions.
    AIDS. 2021;35:155-157.
    >> Share

  39. ZIEGLER MC, Naidoo K, Chapel A, Nkotwana S, et al
    HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.
    AIDS. 2021;35:151-154.
    >> Share

  40. RAMASWAMI R, Lurain K, Marshall VA, Rupert A, et al
    Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
    AIDS. 2021;35:53-62.
    >> Share

    December 2020
  41. LAM JO, Hou CE, Hojilla JC, Anderson AN, et al
    Comparison of dementia risk after age 50 between individuals with and without HIV infection.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  42. BRANDAO M, Bruzzone M, Franzoi MA, de Angelis C, et al
    Impact of HIV infection on baseline characteristics and survival of women with breast cancer: a systematic review and meta-analysis.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  43. RITTENHOUSE KJ, Mwape H, Nelson JA, Mwale J, et al
    Maternal HIV, antiretroviral timing, and spontaneous preterm birth in an urban Zambian cohort: the role of local and systemic inflammation.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  44. NTHOBATSANG K, Ncenga TL, Mwangi-Woto C, Wedu TJ, et al
    Lack of RH2 gene expression may have influenced the HIV pandemic in sub-Saharan Africa.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  45. BUDD A, Krentz HB, Rubin LH, Power C, et al
    Long-term consequences of interpersonal violence experiences on treatment engagement and health status in people living with HIV.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  46. NGONGO NM, Nani-Tuma HS, Mambimbi MM, Mashi ML, et al
    Progressive phasing out of baseline CD4 cell count testing for people living with HIV in Kinshasa, DRC.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  47. TORDOFF DM, Buskin S, Lechtenberg R, Golden MR, et al
    Combining traditional and molecular epidemiology methods to quantify local HIV transmission among foreign-born residents of King County, Washington.
    AIDS. 2020 Dec 10. doi: 10.1097/QAD.0000000000002783.
    >> Share

  48. KIMURA CMS, Nahas CSR, Silva-Filho EV, Ribeiro VL, et al
    High-risk HPV test in anal smears: can it optimize the screening for anal cancer?
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002795.
    >> Share

  49. HICKEY MD, Imbert E, Glidden DV, Rosario JBD, et al
    Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP).
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002793.
    >> Share

  50. MOCROFT A
    The relationship between smoking, current CD4, viral load and cancer in persons living with HIV.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002791.
    >> Share

  51. FALASCA K, Lanuti P, Ucciferri C, Pieragostino D, et al
    Circulating extracellular vesicles as new inflammation marker in hiv infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002794.
    >> Share

  52. HANDOKO R, Chan P, Jagodzinski L, Pinyakorn S, et al
    Minimal detection of cerebrospinal fluid escape after initiation of antiretroviral therapy in acute HIV-1 infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002786.
    >> Share

  53. MU W, Sharma M, Heymans R, Ritou E, et al
    ApoA-I mimetics attenuate macrophage activation in chronic treated HIV.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002785.
    >> Share

  54. XIANG Y, Fujimoto K, Li F, Wang Q, et al
    Identifying influential neighbors in social networks and venue affiliations among young MSM: A data science approach to predict HIV infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002784.
    >> Share

  55. FIORENTINO M, Eubanks A, Coulaud PJ, Couderc C, et al
    Homonegativity, sexual violence and condom use with women in men who have sex with men and women in West Africa (CohMSM).
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002782.
    >> Share

  56. ESTCOURT C, Yeung A, Nandwani R, Goldberg D, et al
    Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM.
    AIDS. 2020 Dec 7. doi: 10.1097/QAD.0000000000002790.
    >> Share

  57. BAILEY JV, Wayal S, Aicken CRH, Webster R, et al
    Interactive digital interventions for prevention of sexually transmitted HIV: systematic review and meta-analyses.
    AIDS. 2020 Dec 4. doi: 10.1097/QAD.0000000000002780.
    >> Share

  58. ONG JJ, Chow EPF, Read D, Taj U, et al
    Nudgeathons to control HIV: designing strategies using behavioural economics.
    AIDS. 2020;34:2337-2340.
    >> Share

  59. AVDOSHINA V, Mocchetti I
    HIV-associated neurodegenerative disorders: extracellular and intracellular mechanisms.
    AIDS. 2020;34:2334-2336.
    >> Share

  60. ZHAO T
    HIV-associated neurodegenerative disorders: role of endoplasmic reticulum in Gp120-mediated neurotoxicity.
    AIDS. 2020;34:2333-2334.
    >> Share

  61. VINIKOOR MJ, Hachaambwa L
    Advanced HIV disease during the 'Treat All' era in Botswana.
    AIDS. 2020;34:2321-2323.
    >> Share

  62. ZIMMERMANN HML, Jongen VW, Boyd A, Hoornenborg E, et al
    Decision-making regarding condom use among daily and event-driven users of preexposure prophylaxis in the Netherlands.
    AIDS. 2020;34:2295-2304.
    >> Share

  63. MONACO DC, Zapata L, Hunter E, Salomon H, et al
    Resistance profile of HIV-1 quasispecies in patients under treatment failure using single molecule, real-time sequencing.
    AIDS. 2020;34:2201-2210.
    >> Share

  64. ABRAHAMS N, Mhlongo S, Dunkle K, Chirwa E, et al
    Increase in HIV incidence in women exposed to rape: a comparative cohort study.
    AIDS. 2020 Dec 1. doi: 10.1097/QAD.0000000000002779.
    >> Share

  65. WOOD BR
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: integrating systematic review findings into practice and policy.
    AIDS. 2020;34:2319-2320.
    >> Share

    November 2020
  66. MARTY L, Lemsalu L, Kivite-Urtane A, Costagliola D, et al
    Revealing HIV epidemic dynamics and contrasting responses in two WHO Eastern European countries: insights from modeling and data triangulation.
    AIDS. 2020 Nov 30. doi: 10.1097/QAD.0000000000002778.
    >> Share

  67. SEYEDALINAGHI S, Taj L, Mazaheri-Tehrani E, Ahsani-Nasab S, et al
    HIV in Iran: onset, responses and future directions.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002757.
    >> Share

  68. XIA Y, Milwid RM, Godin A, Boily MC, et al
    Accuracy of self-reported HIV testing history and awareness of HIV-positive status among people living with HIV in four Sub-Saharan African countries.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002759.
    >> Share

  69. SUNDERMANN EE, Fields A, Saloner R, Gouaux B, et al
    The utility of olfactory function in distinguishing early stage Alzheimer's disease from HIV-associated neurocognitive disorder.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002761.
    >> Share

  70. MCFALL AM, Lau B, Latkin C, Srikrishnan AK, et al
    Optimizing respondent driven sampling to find undiagnosed HIV-infected people who inject drugs.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002763.
    >> Share

  71. ROSEBUSH JC, Best BM, Chadwick EG, Butler K, et al
    Pharmacokinetics and safety of maraviroc in neonates.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002762.
    >> Share

  72. TREVILLYAN JM, Dart A, Paul E, Cavassini M, et al
    Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk; a randomised, controlled trial.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002764.
    >> Share

  73. DESMONDE S, Ciaranello AL, Malateste K, Musick B, et al
    Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus non-perinatally-acquired HIV.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002765.
    >> Share

  74. HUAMAN MA, Juchnowski SM, Zidar DA, Kityo CM, et al
    Monocyte activation in persons living with HIV and tuberculosis coinfection.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002766.
    >> Share

  75. BROOKS KM, Momper JD, Pinilla M, Stek AM, et al
    Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002767.
    >> Share

  76. COOLEY SA, Paul RH, Strain JF, Boerwinkle A, et al
    Effects of anticholinergic medication use on brain integrity in persons living with HIV and persons without HIV.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002768.
    >> Share

  77. BOETTIGER DC, Kerr S, Chattranukulchai P, Siwamogsatham S, et al
    Maintenance of statin therapy among people living with HIV.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002769.
    >> Share

  78. GROENE EA, Valeris-Chacin RJ, Stadelman AM, Safo SE, et al
    Maternal HIV and child anthropometric outcomes over time: An analysis of Zimbabwe demographic health surveys from 2005-2015.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002772.
    >> Share

  79. BAKER JV, Wolfson J, Collins G, Morse C, et al
    Losartan to reduce inflammation and fibrosis endpoints in HIV disease (LIFE-HIV): results from a randomized placebo-controlled trial.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002773.
    >> Share

  80. ZEZIULIN O, Mollan KR, Shook-Sa BE, Hanscom B, et al
    Depressive symptoms and use of HIV care and medication-assisted treatment among people living with HIV who inject drugs.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002774.
    >> Share

  81. TSHIKUNG ON, Smit M, Marinosci A, Buvelot H, et al
    Caring for people living with HIV during the global COVID-19 pandemic.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002775.
    >> Share

  82. GARCIA M, Morcilla V, Navarrete-Munoz MA, Fisher K, et al
    HIV-DNA Content in pTfh Cells is Associated with Residual Viremia in Elite Controllers.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002776.
    >> Share

  83. VELLOZA J, Kapogiannis B, Bekker LG, Celum C, et al
    Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth PrEP services?
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002777.
    >> Share

  84. HUGHES K, Chang J, Stadtler H, Wyatt C, et al
    HIV-1 infection of the kidney: mechanisms and implications.
    AIDS. 2020 Nov 20. doi: 10.1097/QAD.0000000000002753.
    >> Share

  85. CHOW FC, Ma Y, Manion M, Rupert A, et al
    Factors associated with worse cerebrovascular function in aging women with and at risk for HIV.
    AIDS. 2020 Nov 20. doi: 10.1097/QAD.0000000000002755.
    >> Share


  86. Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases Consensus panel: Erratum.
    AIDS. 2020;34:2161-2163.
    >> Share


  87. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients: Erratum.
    AIDS. 2020;34:2159.
    >> Share

  88. MUCCINI C, Spagnuolo V, Canetti D, Bigoloni A, et al
    Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance.
    AIDS. 2020;34:2152-2155.
    >> Share

  89. SOUDEYNS H, Dumond J
    Unexpectedly low levels of transplacental transfer of second-generation integrase strand transfer inhibitors bictegravir and cabotegravir.
    AIDS. 2020;34:2137-2139.
    >> Share

  90. FARR ZUEND C, Noel-Romas L, Hoger S, Mccorriser S, et al
    Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002751.
    >> Share

  91. BEDIMO RJ, Park LS, Shebl F, Sigel K, et al
    Statin exposure and risk of cancer in people with and without HIV infection.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002748.
    >> Share

  92. SEVERIN D, Faiza B, Nadia M, Aurelie DT, et al
    Kaposi sarcoma in people living with HIV: a comparative study of classic and HIV-viremic and aviremic AIDS Kaposi Sarcoma.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002744.
    >> Share

  93. ADAMS JW, Khan MR, Bessey SE, Friedman SR, et al
    Pre-exposure prophylaxis (PrEP) strategies for African American Women Affected by Mass Incarceration: A Modeling Study.
    AIDS. 2020 Nov 9. doi: 10.1097/QAD.0000000000002749.
    >> Share

  94. REIN SM, Lampe FC, Johnson MA, Bhagani S, et al
    All-cause hospitalisation according to demographic group in people living with HIV in the current ART era: Recent findings from a cohort study in the UK.
    AIDS. 2020 Nov 9. doi: 10.1097/QAD.0000000000002750.
    >> Share

  95. NICHOLS BE, Cele R, Jamieson L, Long LC, et al
    Community-based delivery of HIV treatment in Zambia: costs and outcomes.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002737.
    >> Share

  96. COLLINS LF, Colasanti JA, Nguyen ML, Moran CA, et al
    The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the U.S. - applying lessons from high-burden settings.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002746.
    >> Share

  97. PASVOL TJ, Teh J, Balfoussia D, Hall R, et al
    Outcomes of fertility investigations in a cohort of adults with perinatally acquired HIV-1 infection: a UK cross-sectional observational study.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002745.
    >> Share

  98. TAGO A, McKinnon LR, Wanjiru T, Muriuki F, et al
    Declines in HIV prevalence in female sex workers (FSWs) accessing an HIV treatment and prevention programme in Nairobi, Kenya over a 10-year period.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002747.
    >> Share


  99. Assessing the validity of and factors that influence accurate self-reporting of HIV status after testing: a population-based study: Erratum.
    AIDS. 2020;34:1993.
    >> Share

  100. GREEN M
    A letter to a young HIV doctor.
    AIDS. 2020;34:1991-1992.
    >> Share

  101. GABUZDA D, McArthur JC, Letendre SL
    Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system.
    AIDS. 2020;34:1975-1977.
    >> Share

  102. PYRA M, Rusie L, Castro M, Keglovitz Baker K, et al
    A taxonomy of pragmatic measures of HIV preexposure prophylaxis use.
    AIDS. 2020;34:1951-1957.
    >> Share

  103. MILIC J, Menozzi V, Schepis F, Malagoli A, et al
    Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
    AIDS. 2020;34:1915-1921.
    >> Share

  104. LO B
    Toward respectful research with Indigenous people.
    AIDS. 2020;34:1979-1981.
    >> Share

    October 2020
  105. SUGAWARA S, Manickam C, Reeves RK
    TRIGGERED: could refocused cell signaling be key to NK cell-based HIV immunotherapeutics?
    AIDS. 2020 Oct 27. doi: 10.1097/QAD.0000000000002743.
    >> Share

  106. SHERMAN BT, Hu X, Singh K, Haine L, et al
    Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.
    AIDS. 2020 Oct 20. doi: 10.1097/QAD.0000000000002738.
    >> Share

  107. CHANDIWANA NC, Chersich M, Venter WF, Akpomiemie G, et al
    Unexpected interactions between dolutegravir and folate: randomised trial evidence from South Africa.
    AIDS. 2020 Oct 20. doi: 10.1097/QAD.0000000000002741.
    >> Share

  108. CHLOE O, Elion R, Thompson M, Rockstroh JK, et al
    Changes in weight and body mass index with first-line doravirine-based therapy: a pooled analysis of three randomized controlled trials.
    AIDS. 2020 Oct 13. doi: 10.1097/QAD.0000000000002725.
    >> Share

  109. PINTYE J, Huo Y, Kacanek D, Zhang K, et al
    Detectable HIV RNA in late pregnancy associated with low tenofovir hair levels at time of delivery among women living with HIV in the United States.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002730.
    >> Share

  110. TEMU TM, Zifodya JS, Polyak SJ, Wagoner J, et al
    Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002729.
    >> Share

  111. BAJEMA KL, Nance RM, Delaney JAC, Eaton E, et al
    Significant decline in heavily treatment experienced persons with HIV with limited antiretroviral treatment options in the US, 2000-2017.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002679.
    >> Share

  112. WHITEMAN A, Baugher A, Sionean C
    Assessing self-reported discrimination among men who have sex with men.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002711.
    >> Share

  113. LU D, Sun H, Yu J, Kuang YQ, et al
    Chemsex drugs regulate HIV infection and replication in immune cells: A vicious circle.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002708.
    >> Share

  114. KOHLI M, Moore DJ, Moore RC
    Using health technology to capture digital phenotyping data in HIV-associated neurocognitive disorders.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002726.
    >> Share

  115. GILMORE JC, Serghides L, Bendayan R
    Differential effects of antiretroviral drug toxicity in male versus female children who are HIV-exposed but uninfected.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002707.
    >> Share

  116. DES JARLAIS DC, Duong Thi H, Khuat Thi Hai O, Feelemyer JP, et al
    Ending an HIV epidemic among persons who inject drugs (PWID) in a middle-income country: extremely low HIV incidence among PWID in Hai Phong, Viet Nam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002712.
    >> Share

  117. ROURKE SB, Bekele T, Rachlis A, Kovacs C, et al
    Asymptomatic neurocognitive impairment is a risk for symptomatic decline in a large HIV Canadian cohort study.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002709.
    >> Share

  118. AUDET CM, Ngobeni S, Mkansi M, Wafawanaka F, et al
    An unrecognized key population? traditional treatment practices associated with HIV risk among traditional healers in rural South Africa.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002710.
    >> Share

  119. SHANGANI S, Bhaskar N, Richmond N, Operario D, et al
    A systematic review of early adoption of implementation science for HIV prevention or treatment in the United States.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002713.
    >> Share

  120. ZIMMERMANN HML, Jongen VW, Boyd A, Hoornenborg E, et al
    Decision-making regarding condom use among daily and event-driven users of pre-exposure prophylaxis in the Netherlands - a mixed-methods analysis.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002714.
    >> Share

  121. SIBIUDE J, Le Chenadec J, Mandelbrot L, Dollfus C, et al
    Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002719.
    >> Share

  122. NJUGUNA IN, Wagner AD, Neary J, Omondi VO, et al
    Financial incentives to increase pediatric hiv testing: a randomized trial.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002720.
    >> Share

  123. CARLANDER C, Wagner P, Yilmaz A, Sparen P, et al
    Employment by HIV status, mode of HIV transmission and migrant status: a nation-wide population-based study with twenty years of follow-up.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002724.
    >> Share

  124. SHANAUBE K, Schaap A, Hoddinott G, Mubekapi-Musadaidzwa C, et al
    Impact of a community-wide combination HIV prevention intervention on knowledge of HIV status among adolescents.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002722.
    >> Share

  125. HSU R, Brunet L, Fusco JS, Mounzer K, et al
    Incident Type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002718.
    >> Share

  126. JONES CI, Rose SL, Shutt A, Cairo C, et al
    Maternal HIV status skews transcriptomic response in infant cord blood monocytes exposed to BCG.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002706.
    >> Share

  127. ZHANG J, Thakuri BKC, Zhao J, Nguyen LN, et al
    LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002700.
    >> Share

  128. HESSOL NA, Barrett BW, Margolick JB, Plankey M, et al
    Risk of smoking-related cancers among women and men living with and without hiv.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002717.
    >> Share

  129. WAGMAN JA, Wynn A, Matsuzaki M, Gnatienko N, et al
    Hazardous alcohol use, antiretroviral therapy receipt and viral suppression in people living with HIV who inject drugs in the U.S., India, Russia and Vietnam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002716.
    >> Share

  130. VONASEK B, Kay A, Devezin T, Bacha JM, et al
    Tuberculosis symptom screening for children and adolescents living with HIV in six high HIV/TB burden countries in Africa.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002715.
    >> Share

  131. ZIEGLER MC, Naidoo K, Chapel A, Nkotwana S, et al
    HIV-1 evades a gag mutation that abrogates KIR binding and disinhibits NK cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002721.
    >> Share

  132. PILKINGTON V, Hughes SL, Pepperrell T, McCann K, et al
    Tenofovir alafenamide versus tenofovir disoproxil fumarate - an updated meta-analysis of 14,894 patients across 14 trials.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002699.
    >> Share

  133. MURAKOSHI H, Chikata T, Akahoshi T, Zou C, et al
    Critical effect of Pol escape mutations associated with detrimental allele HLA-C*15: 05 on clinical outcome in HIV-1 subtype A/E infection.
    AIDS. 2020 Oct 6. doi: 10.1097/QAD.0000000000002704.
    >> Share

  134. SERRANO PA, Daubert E, Munoz A, Hosek SG, et al
    Effect of Truvada lawsuit advertising on PrEP attitudes and decisions among sexual and gender minority youth and young adults at risk for HIV.
    AIDS. 2020 Oct 6. doi: 10.1097/QAD.0000000000002728.
    >> Share

  135. DI BIAGIO A, Taramasso L, Dentone C, Vena A, et al
    Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients?
    AIDS. 2020;34:1865-1867.
    >> Share

  136. CONWAY B
    Treatment of primary HIV infection: new data for a new era.
    AIDS. 2020;34:1855-1856.
    >> Share

  137. SANTOS ME, Protopopescu C, Ribero RA, Benzaken AS, et al
    Population attributable fractions of mortality in people living with HIV: roles of delayed antiretroviral therapy, hepatitis coinfections and social factors.
    AIDS. 2020;34:1843-1854.
    >> Share

  138. BENNETT SJ, Chunda-Liyoka C, Poppe LK, Meinders K, et al
    High nonnucleoside reverse transcriptase inhibitor resistance levels in HIV-1-infected Zambian mother-infant pairs.
    AIDS. 2020;34:1833-1842.
    >> Share

  139. CHARRE C, Icard V, Pradat P, Brochier C, et al
    Coronavirus disease 2019 attack rate in HIV-infected patients and in preexposure prophylaxis users.
    AIDS. 2020;34:1765-1770.
    >> Share

  140. PASTAKIA SD, Braitstein P, Galarraga O, Genberg B, et al
    Preserving 2 decades of healthcare gains for Africa in the coronavirus disease 2019 era.
    AIDS. 2020;34:1761-1763.
    >> Share

  141. SAAG M
    Special section: COVID-19 among people living with HIV.
    AIDS. 2020;34:1755-1756.
    >> Share

  142. MAI B, Wang W, Lin M, Hu S, et al
    HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients.
    AIDS. 2020;34:1735-1743.
    >> Share

  143. GRANT M
    Regulation of natural killer cells: analog peptide handshake goes digital.
    AIDS. 2020;34:1857-1858.
    >> Share

  144. EL-SADR WM
    What one pandemic can teach us in facing another.
    AIDS. 2020;34:1757-1759.
    >> Share

    September 2020
  145. MONACO DC, Zapata L, Hunter E, Salomon H, et al
    Resistance Profile of Human Immunodeficiency Virus 1 (HIV-1) Quasispecies in Patients Under Treatment Failure Using Single Molecule, Real-Time (SMRT) Sequencing.
    AIDS. 2020 Sep 25. doi: 10.1097/QAD.0000000000002697.
    >> Share

  146. LEVY JA
    The need to reassess our approaches at HIV cure and prevention.
    AIDS. 2020 Sep 25. doi: 10.1097/QAD.0000000000002695.
    >> Share

  147. RAMASWAMI R, Lurain K, Marshall VA, Rupert A, et al
    Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other KSHV-associated disorders.
    AIDS. 2020 Sep 17. doi: 10.1097/QAD.0000000000002692.
    >> Share

  148. CHIAO E, Lensing SY, Wiley DJ, Deshmukh AA, et al
    Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV.
    AIDS. 2020 Sep 17. doi: 10.1097/QAD.0000000000002694.
    >> Share

  149. MUCCINI C, Spagnuolo V, Canetti D, Bigoloni A, et al
    CSF viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002687.
    >> Share

  150. WILSON IB, Tie Y, Padilla M, Rogers WH, et al
    Performance of a short, self-report adherence scale in a probability sample of persons using HIV antiretroviral therapy in the United States.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002689.
    >> Share

  151. BOUVIN-PLEY M, Leoz M, Roch E, Moreau A, et al
    Differential utilization of CD4 by transmitted/founder and chronic envelope glycoproteins in a MSM HIV-1 subtype B transmission cluster.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002690.
    >> Share

  152. AMBROSIONI J, Farrera J, de Lazzari E, Nicolas D, et al
    Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002685.
    >> Share

  153. TELWATTE S, Kim P, Chen TH, Milush JM, et al
    Mechanistic differences underlying HIV latency in the gut and blood contribute to differential responses to latency-reversing agents.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002684.
    >> Share

  154. O'REILLY KR, Fonner VA, Kennedy CE, Yeh PT, et al
    The paradox of HIV prevention: did biomedical prevention trials show how effective behavioral prevention can be?
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002682.
    >> Share

  155. TSONDAI PR, Braithewaite K, Fatti G, Bolton-Moore C, et al
    Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002683.
    >> Share

  156. JENNESS SM, Johnson JA, Hoover KW, Smith DK, et al
    Modeling an integrated HIV prevention and care continuum to achieve the ending the HIV epidemic goals.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002681.
    >> Share

  157. FEELEMYER J, Arasteh K, Thi HD, Hai OKT, et al
    Associations between methamphetamine use and lack of viral suppression among a cohort of HIV positive persons who inject drugs in hai phong vietnam.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002680.
    >> Share

  158. MAHTAB S, Scott C, Asafu-Agyei NAA, Machemedze T, et al
    Prevalence and predictors of bone health among perinatally HIV-infected adolescents.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002686.
    >> Share

  159. BANDA FM, Powis KM, Sun S, Makhema J, et al
    Fetal biometry following in utero exposure to dolutegravir- or efavirenz-based antiretroviral therapy.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002674.
    >> Share

  160. AGRATI C, De Biasi S, Fidanza L, Gibellini L, et al
    The importance of advanced cytometry in defining new immune cell types and functions relevant for the immunopathogenesis of HIV infection.
    AIDS. 2020 Sep 7. doi: 10.1097/QAD.0000000000002675.
    >> Share

  161. PUJARI S, Gugale P, Shah D, Patel D, et al
    Pulmonary Tuberculosis masquerading as COVID19 in an HIV infected individual with advanced immune suppression.
    AIDS. 2020 Sep 7. doi: 10.1097/QAD.0000000000002676.
    >> Share

  162. SPINELLI MA, Hickey MD, Glidden DV, Nguyen JQ, et al
    Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19.
    AIDS. 2020 Sep 7. doi: 10.1097/QAD.0000000000002677.
    >> Share

  163. FUSCO FM, Sangiovanni V, Tiberio C, Papa N, et al
    Persons living with HIV may be reluctant to access to COVID-19 testing services: data from "D. Cotugno" hospital, naples, southern Italy.
    AIDS. 2020 Sep 7. doi: 10.1097/QAD.0000000000002678.
    >> Share

  164. MOLINA-ITURRITZA E, San-Jose-Muniz I, Ganchegui-Aguirre M, Balerdi-Sarasola L, et al
    Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain.
    AIDS. 2020;34:1696-1697.
    >> Share

  165. SASSET L, Di Meco E, Cavinato S, Cattelan AM, et al
    Coinfection of severe acute respiratory syndrome coronavirus 2 and HIV in a teaching hospital: still much to learn.
    AIDS. 2020;34:1694-1696.
    >> Share

  166. FREER J
    Human papilloma virus-related cancers: MSM and trans people living with HIV are still getting left behind.
    AIDS. 2020;34:1692-1694.
    >> Share

  167. GUNST JD, Schleimann MH, Pahus MH, Ostergaard L, et al
    HIV-1 acquisition in a man with ulcerative colitis on anti-alpha4beta7 mAb vedolizumab treatment.
    AIDS. 2020;34:1689-1692.
    >> Share

  168. BEDIMO RJ, Adams-Huet B, Nguyen V, Moore-Matthews D, et al
    Changes in bone microarchitecture with abacavir--lamivudine versus tenofovir disoproxil fumarate--emtricitabine in adults living with HIV.
    AIDS. 2020;34:1687-1689.
    >> Share

  169. CACHAY ER, Torriani FJ, Hill L, Jain S, et al
    The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV.
    AIDS. 2020;34:1681-1683.
    >> Share

  170. CHRISTOPOULOS KA, Neilands TB, Dilworth S, Lisha N, et al
    Internalized HIV stigma predicts subsequent viremia in US HIV patients through depressive symptoms and antiretroviral therapy adherence.
    AIDS. 2020;34:1665-1671.
    >> Share

  171. DIRAJLAL-FARGO S, Yu J, Albar Z, Sattar A, et al
    Monocyte activation and gut barrier dysfunction in South African youth on antiretroviral therapy and their associations with endothelial dysfunction.
    AIDS. 2020;34:1615-1623.
    >> Share

  172. DHANDE JR, Saikia K, Singh DP, Bagul RD, et al
    Higher frequencies of functional HIV-envelope-specific memory B cells are associated with nonprogressive HIV infection in Indian population.
    AIDS. 2020;34:1603-1608.
    >> Share

  173. SIRAPRAPASIRI T, Srithanaviboonchai K, Chantcharas P, Suwanphatthana N, et al
    Integration and scale-up of efforts to measure and reduce HIV-related stigma: the experience of Thailand.
    AIDS. 2020;34 Suppl 1:S103-S114.
    >> Share

  174. NYBLADE L, Mbuya-Brown RJ, Ezekiel MJ, Addo NA, et al
    A total facility approach to reducing HIV stigma in health facilities: implementation process and lessons learned.
    AIDS. 2020;34 Suppl 1:S93-S102.
    >> Share

  175. SINGH RJ, Sarna A, Schensul JJ, Mahapatra B, et al
    A multilevel intervention to reduce stigma among alcohol consuming men living with HIV receiving antiretroviral therapy: findings from a randomized control trial in India.
    AIDS. 2020;34 Suppl 1:S83-S92.
    >> Share

  176. YIGIT I, Modi RA, Weiser SD, Johnson MO, et al
    Effects of an intervention on internalized HIV-related stigma for individuals newly entering HIV care.
    AIDS. 2020;34 Suppl 1:S73-S82.
    >> Share

  177. LYONS CE, Olawore O, Turpin G, Coly K, et al
    Intersectional stigmas and HIV-related outcomes among a cohort of key populations enrolled in stigma mitigation interventions in Senegal.
    AIDS. 2020;34 Suppl 1:S63-S72.
    >> Share

  178. BROADY TR, Brener L, Hopwood M, Cama E, et al
    HIV stigma by association among Australian gay and bisexual men.
    AIDS. 2020;34 Suppl 1:S53-S62.
    >> Share

  179. YAM EA, Pulerwitz J, Almonte D, Garcia F, et al
    Stigma among key populations living with HIV in the Dominican Republic: experiences of people of Haitian descent, MSM, and female sex workers.
    AIDS. 2020;34 Suppl 1:S43-S52.
    >> Share

  180. GEIBEL S, Gottert A, Friedland BA, Jeremiah K, et al
    Internalized stigma among people living with HIV: assessing the Internalized AIDS-Related Stigma Scale in four countries.
    AIDS. 2020;34 Suppl 1:S33-S42.
    >> Share

  181. GOTTERT A, McClair TL, Pulerwitz J, Friedland BA, et al
    What shapes resilience among people living with HIV? A multi-country analysis of data from the PLHIV Stigma Index 2.0.
    AIDS. 2020;34 Suppl 1:S19-S32.
    >> Share

  182. FRIEDLAND BA, Gottert A, Hows J, Baral SD, et al
    The People Living with HIV Stigma Index 2.0: generating critical evidence for change worldwide.
    AIDS. 2020;34 Suppl 1:S5-S18.
    >> Share

  183. SEELEY J, Blanc AK
    Reducing stigma and discrimination: new evidence and its implications.
    AIDS. 2020;34 Suppl 1:S1-S4.
    >> Share

    August 2020
  184. GOERLICH E, Mukherjee M, Schar M, Brown TT, et al
    Noninvasive detection of impaired pulmonary artery endothelial function in people living with HIV.
    AIDS. 2020 Aug 20. doi: 10.1097/QAD.0000000000002671.
    >> Share

  185. STRATHDEE SA, Kuo I, El-Bassel N, Hodder S, et al
    Preventing HIV outbreaks among people who inject drugs in the United States: Plus ca change, plus ca meme chose.
    AIDS. 2020 Aug 20. doi: 10.1097/QAD.0000000000002673.
    >> Share

  186. HADI YB, Naqvi SFZ, Kupec JT, Sarwari AR, et al
    Characteristics and outcomes of COVID-19 in patients with HIV: a multi-center research network study.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002666.
    >> Share

  187. ZANG X, Krebs E, Mah C, Min JE, et al
    Can the 'Ending the HIV Epidemic' initiative transition the US towards HIV/AIDS epidemic control?
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002668.
    >> Share

  188. PINEIRO F, Climent F, Imaz A, Gudiol C, et al
    Clinical and pathological features of kaposi sarcoma herpesvirus inflammatory cytokine syndrome: case report and review of the literature.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002669.
    >> Share

  189. DI BIAGIO A, Ricci E, Calza L, Squillace N, et al
    Factors associated with hospital admission for COVID-19 in HIV patients.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002663.
    >> Share

  190. D'ELBEE M, Makhetha MC, Jubilee M, Taole M, et al
    Using HIV self-testing to increase the affordability of community-based HIV testing services: A longitudinal analysis in Lesotho.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002664.
    >> Share

  191. BROCHADO-KITH O, Martinez I, Berenguer J, Medrano LM, et al
    Near normalization of peripheral blood markers in HIV-infected patients on long-term suppressive antiretroviral therapy: a case-control study.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002645.
    >> Share

  192. PENCOLE L, Le MP, Bouchet-Crivat F, Duro D, et al
    Placental Transfer of the integrase strand inhibitors cabotegravir and bictegravir in the Ex-Vivo Human Cotyledon Perfusion Model.
    AIDS. 2020 Aug 10. doi: 10.1097/QAD.0000000000002637.
    >> Share

  193. ROSE R, Cross S, Lamers SL, Astemborski J, et al
    Persistence of HIV transmission clusters among people who inject drugs.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002662.
    >> Share

  194. REN M, Szadkowski L, Walmsley SL
    Deciphering the serological response to syphilis treatment in men living with HIV: do we meet the definitions for cure?
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002656.
    >> Share

  195. SABIN CA, Harding R, Bagkeris E, Geressu A, et al
    The predictors of pain extent in people living with HIV.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002660.
    >> Share

  196. DEZANET LNC, Maylin S, Gabassi A, Rougier H, et al
    Correlation of serum hepatitis B core-related antigen with HBV total intrahepatic DNA and ccc-DNA viral load in HIV-hepatitis B coinfection.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002659.
    >> Share

  197. COUTIFARIS P, Byrd D, Childs J, Clark U, et al
    Neurobehavioral outcomes in young adults with perinatally-acquired HIV.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002655.
    >> Share

  198. YUNIHASTUTI E, Teeratakulpisarn N, Jeo WS, Nilasari H, et al
    Incidence, clearance, persistence and factors related with high-risk anal HPV persistence in South-East Asian MSM and transgender women.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002654.
    >> Share

  199. SAAG M
    Editor's comment.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002648.
    >> Share

  200. ETIENNE N, Karmochkine M, Slama L, Pavie J, et al
    HIV infection and COVID-19: risk factors for severe disease.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002651.
    >> Share

  201. SHPONKA V, Reveles CY, Alam S, Jaramillo M, et al
    Frequent expression of activation induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIV.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002653.
    >> Share

  202. GAY CL, Neo DT, Devanathan AS, Kuruc JD, et al
    Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002652.
    >> Share

  203. MILIC J, Menozzi V, Schepis F, Malagoli A, et al
    Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002650.
    >> Share

  204. EVANS C, Chasekwa B, Rukobo S, Govha M, et al
    Inflammation, cytomegalovirus and the growth hormone axis in HIV-exposed uninfected Zimbabwean infants.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002646.
    >> Share

  205. INCIARTE A, Gonzalez-Cordon A, Rojas J, Torres B, et al
    Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV: a single-center, prospective observational study.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002643.
    >> Share

  206. ASSOUMOU L, Racine C, Fellahi S, Lamaziere A, et al
    Fat gain differs by sex and hormonal status in persons living with suppressed HIV switched to raltegravir/etravirine.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002644.
    >> Share

  207. STANGL AL, Pliakas T, Mainga T, Steinhaus M, et al
    The effect of universal testing and treatment on HIV stigma in 21 communities in Zambia and South Africa: results from a cluster randomised trial.
    AIDS. 2020 Aug 6. doi: 10.1097/QAD.0000000000002658.
    >> Share

  208. TOZZI B, Gavioli C, Linhares L, Entringer M, et al
    Pruritic papular eruption in HIV-positive patients in Brazil.
    AIDS. 2020;34:1576-1578.
    >> Share

  209. CHIRWA M, Mazzitelli M, Pereira B, Milinkovic A, et al
    Incidental findings in elderly people living with HIV undergoing computed tomography coronary artery calcium scoring.
    AIDS. 2020;34:1573-1575.
    >> Share

  210. LATINI A, Alei L, Magri F, Eibenschutz L, et al
    Nonmelanoma skin cancer and melanoma in HIV-1-infected patients.
    AIDS. 2020;34:1570-1572.
    >> Share

  211. INZAULE SC, Bertagnolio S, Kityo CM, Siwale M, et al
    The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa.
    AIDS. 2020;34:1559-1566.
    >> Share

  212. CLOSSON K, McLinden T, Parry R, Lee M, et al
    Severe intimate partner violence is associated with all-cause mortality among women living with HIV.
    AIDS. 2020;34:1549-1558.
    >> Share

  213. LESKO CR, Chander G, Moore RD, Lau B, et al
    Variation in estimated viral suppression associated with the definition of viral suppression used.
    AIDS. 2020;34:1519-1526.
    >> Share

  214. MERCHANTE N, Rodriguez-Fernandez M, Figueruela B, Rodriguez-Arrondo F, et al
    Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients.
    AIDS. 2020;34:1497-1507.
    >> Share

  215. MOCROFT A, Ryom L, Oprea C, Li Q, et al
    Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons.
    AIDS. 2020;34:1485-1495.
    >> Share

  216. TITANJI K, Ofotokun I, Weitzmann MN
    Immature/transitional B-cell expansion is associated with bone loss in HIV-infected individuals with severe CD4+ T-cell lymphopenia.
    AIDS. 2020;34:1475-1483.
    >> Share

  217. PINACCHIO C, Scagnolari C, Iebba V, Santinelli L, et al
    High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients.
    AIDS. 2020;34:1467-1473.
    >> Share

  218. GIRON LB, Azzoni L, Yin X, Lynn KM, et al
    Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individuals.
    AIDS. 2020;34:1461-1466.
    >> Share

  219. SAHBANDAR IN, Chew GM, Corley MJ, Pang APS, et al
    Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockade.
    AIDS. 2020;34:1451-1460.
    >> Share

  220. KAHN J
    The changing HIV epidemic: a view from the front line in the United States.
    AIDS. 2020;34:1437-1438.
    >> Share

  221. SU J, Shen X, Ni Q, Zhao H, et al
    Infection of severe acute respiratory syndrome coronavirus 2 in a patient with AIDS.
    AIDS. 2020;34:1575-1576.
    >> Share

    July 2020
  222. WINSTON A, De Francesco D, Post F, Boffito M, et al
    Comorbidity Indices in People with HIV and Considerations for COVID-19 Outcomes.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002606.
    >> Share

  223. DIEPSTRA K, Lu H, McManus KA, Rogawski McQuade ET, et al
    What we talk about when we talk about durable viral suppression.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002612.
    >> Share

  224. CHRISTOPOULOS KA, Neilands TB, Dilworth S, Lisha N, et al
    Internalized HIV stigma predicts subsequent viremia in US HIV patients through depressive symptoms and ART adherence.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002595.
    >> Share

  225. DIRAJLAL-FARGO S, Yu J, Albar Z, Sattar A, et al
    Monocyte activation and gut barrier dysfunction in South African youth on art and their associations with endothelial dysfunction.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002615.
    >> Share

  226. SANTOS ME, Protopopescu C, Ribeiro RA, Benzaken AS, et al
    Population attributable fractions of mortality in people living with HIV: roles of delayed ART, hepatitis coinfections and social factors.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002621.
    >> Share

  227. TOWNSEND SJ, Chunda-Liyoka C, Poppe LK, Meinders K, et al
    High NNRTI resistance levels in HIV-1 infected Zambian mother-infant pairs.
    AIDS. 2020 Jul 23. doi: 10.1097/QAD.0000000000002614.
    >> Share

  228. BOBROW K, Xia F, Hoang T, Valcour V, et al
    HIV and risk of dementia in older veterans.
    AIDS. 2020 Jul 22. doi: 10.1097/QAD.0000000000002597.
    >> Share

  229. PASTAKIA SD, Braitstein P, Galarraga O, Genberg B, et al
    Preserving two decades of healthcare gains for africa in the Covid-19 era.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002605.
    >> Share

  230. GIATSOU E, Abdi B, Plu I, Desire N, et al
    Ultradeep sequencing reveals HIV-1 diversity and resistance compartmentalization during HIV-encephalopathy.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002616.
    >> Share

  231. KNETTEL BA, Mwamba RN, Minja L, Goldston DB, et al
    Exploring patterns and predictors of suicidal ideation among pregnant and postpartum women living with HIV in Kilimanjaro, Tanzania.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002594.
    >> Share

  232. SABO MC, Lehman DA, Pintye JC, Wang B, et al
    Elevation of Cervical CXCL10 Levels is Associated with HIV-1 Acquisition in Pregnant and Postpartum Women.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002613.
    >> Share

  233. CACHAY ER, Torriani FJ, Hill L, Jain S, et al
    The role of barriers to care on the propensity for HCV non-referral among people living with HIV.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002610.
    >> Share

  234. TSHIVUILA-MATALA C, Honeyman S, Nesbitt C, Kirtley S, et al
    Perinatal outcomes associated with antiretroviral therapy: systematic review and network meta-analysis of randomised controlled trials.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002593.
    >> Share

  235. TRUNFIO M, Rugge W, Mighetto L, Vai D, et al
    Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002601.
    >> Share

  236. MAI B, Wang W, Lin M, Hu S, et al
    HIV-Associated plasmablastic lymphoma in the era of highly active antiretroviral therapy: a single center experience of 21 patients.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002590.
    >> Share

  237. HUGHES K, Akturk G, Gnjatic S, Chen B, et al
    Proliferation of HIV-infected renal epithelial cells following virus acquisition from infected macrophages.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002589.
    >> Share

  238. WALL KM, Kilembe W, Inambao M, Hoagland A, et al
    Cost-effectiveness of integrated HIV prevention and family planning services for Zambian couples.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002584.
    >> Share

  239. CHARRE C, Icard V, Pradat P, Brochier C, et al
    COVID-19 attack rate in HIV-infected patients and in PrEP users.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002639.
    >> Share

  240. JONES DL, Alcaide VJR, Luisa M, Carrico A, et al
    Syndemic burden and systemic inflammation, HIV health status, and blood pressure among women with unsuppressed HIV viral loads in the Women's Interagency HIV Study.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002617.
    >> Share

  241. LANG R, Czarnecki C, Kim J, Luider J, et al
    Identification and root-cause analysis of aberrant CD4 counts in an HIV cohort; the importance of quality control in changing laboratory procedure.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002638.
    >> Share

  242. ABDI B, Nguyen T, Brouillet S, Desire N, et al
    No HIV-1 molecular evolution on long term antiretroviral therapy initiated during primary HIV-1 infection.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002629.
    >> Share

  243. PYRA M, Rusie L, Castro M, Baker KK, et al
    A taxonomy of pragmatic measures of HIV pre-exposure prophylaxis (PrEP) Use: application in a PrEP-using cohort in Chicago, IL.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002618.
    >> Share

  244. EGGERS C, Hoetelmans R, Laer S
    Zidovudine and lamivudine reach higher concentrations in ventricular than in lumbar human cerebrospinal fluid.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002626.
    >> Share

  245. MEDINA N, Alastruey-Izquierdo A, Mercado D, Bonilla O, et al
    Comparative performance of the laboratory assays used by a diagnostic laboratory hub for opportunistic infections in people living with HIV.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002631.
    >> Share

  246. DHANDE JR, Saikia K, Singh DP, Bagul RD, et al
    Higher frequencies of functional HIV-Envelope specific memory B cells are associated with non-progressive HIV infection in Indian population.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002620.
    >> Share

  247. FERRARA M, Bumpus NN, Ma Q, Ellis RJ, et al
    Antiretroviral drug concentrations in brain tissue of adult decedents.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002628.
    >> Share

  248. LEBELONYANE R, Mills LA, Mogorosi C, Ussery F, et al
    Advanced HIV disease in the botswana combination prevention project: prevalence, risk factors, and outcomes.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002627.
    >> Share

  249. BOESECKE C
    Recently acquired and early chronic hepatitis C in men having sex with men (MSM): Recommendations from the NEAT-ID consensus panel.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002622.
    >> Share

  250. INZAULE SC, Jordan MR, Cournil A, Giron-Callejas A, et al
    Tenofovir resistance in early and long-term treated patients on first-line antiretroviral therapy in eight low- and middle-income countries.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002623.
    >> Share

  251. ADACHI E, Saito M, Ikeuchi K, Hoshina T, et al
    Cases of coronavirus disease-2019 in HIV-infected transgender women.
    AIDS. 2020;34:1435-1436.
    >> Share

  252. PROIETTI I, Skroza N, Michelini S, Mambrin A, et al
    Efficacy of nivolumab in HIV patient with melanoma brain metastases.
    AIDS. 2020;34:1433-1435.
    >> Share

  253. BERZKALNS AE, Barbee LA, Dombrowski JC, Golden MR, et al
    Low HIV incidence among women following sexually transmitted infection does not support national pre-exposure prophylaxis recommendations.
    AIDS. 2020;34:1429-1431.
    >> Share

  254. ALUFANDIKA M, Lawrence DS, Boyer-Chammard T, Kanyama C, et al
    A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.
    AIDS. 2020;34:1425-1428.
    >> Share

  255. SAMPAIO JDA, Jacome-Santos H, Aires AV, Pinheiro JJV, et al
    Orofacial outcomes in adolescents with perinatally infected HIV in antiretroviral therapy.
    AIDS. 2020;34:1417-1423.
    >> Share

  256. CALVERT C, Marston M, Slaymaker E, Crampin AC, et al
    Direct maternal deaths attributable to HIV in the era of antiretroviral therapy: evidence from three population-based HIV cohorts with verbal autopsy.
    AIDS. 2020;34:1397-1405.
    >> Share

  257. LIANG J, Nosova E, Reddon H, Nolan S, et al
    Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
    AIDS. 2020;34:1389-1396.
    >> Share

  258. LAM E, Hites M, Cantinieaux B, Van Laethem Y, et al
    Malaria in HIV-infected patients in a nonendemic setting.
    AIDS. 2020;34:1359-1365.
    >> Share

  259. HOSSEINI-HOOSHYAR S, Martinello M, Yee J, Read P, et al
    Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    AIDS. 2020;34:1347-1358.
    >> Share

  260. PATEL MR, Mushavi A, Balachandra S, Shambira G, et al
    HIV-exposed uninfected infant morbidity and mortality within a nationally representative prospective cohort of mother-infant pairs in Zimbabwe.
    AIDS. 2020;34:1339-1346.
    >> Share

  261. MWIMANZI F, Ngare I, Toyoda M, Mori M, et al
    An HIV-1 Nef genotype that diminishes immune control mediated by protective human leucocyte antigen alleles.
    AIDS. 2020;34:1325-1330.
    >> Share

  262. SHARMA V, Bryant C, Montero M, Creegan M, et al
    Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.
    AIDS. 2020;34:1289-1301.
    >> Share

  263. COLLINS LF, Moran CA, Oliver NT, Moanna A, et al
    Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GA.
    AIDS. 2020 Jul 14. doi: 10.1097/QAD.0000000000002632.
    >> Share

  264. FEITERNA-SPERLING C, Bukkems VE, Teulen MJA, Colbers AP, et al
    Low raltegravir transfer into the breastmilk of a woman living with HIV.
    AIDS. 2020 Jul 14. doi: 10.1097/QAD.0000000000002624.
    >> Share

  265. COLEMAN H, Snell LB, Simons R, Douthwaite ST, et al
    Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV.
    AIDS. 2020;34:1258-1260.
    >> Share

  266. DI GIAMBENEDETTO S, Del Giacomo P, Ciccullo A, Porfidia A, et al
    SARS-CoV-2 infection in a highly experienced person living with HIV.
    AIDS. 2020;34:1257-1258.
    >> Share

  267. DAUBY N
    Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics.
    AIDS. 2020;34:1255-1256.
    >> Share

  268. CATTANEO D, Minisci D, Formenti T, Negri C, et al
    The prescribing cascade 3.0: a case for recreational drugs in HIV.
    AIDS. 2020;34:1253-1255.
    >> Share

  269. BRENNER BG
    Phylogenetics: an added ingredient in HIV prevention.
    AIDS. 2020;34:1247-1248.
    >> Share

  270. NGUYEN N, Choi CJ, Robbins R, Korich R, et al
    Psychiatric trajectories across adolescence in perinatally HIV-exposed youth: the role of HIV infection and associations with viral load.
    AIDS. 2020;34:1205-1215.
    >> Share

  271. YE L, Wang J, Teque F, Xie F, et al
    Generation of HIV-1-infected patients' gene-edited induced pluripotent stem cells using feeder-free culture conditions.
    AIDS. 2020;34:1127-1139.
    >> Share

  272. ODHIAMBO F, Mulwa E, Ayieko J, Kulzer J, et al
    Implementation of HIV care in Western Kenya during corona virus disease 2019 response.
    AIDS. 2020;34:F1-F2.
    >> Share

    June 2020
  273. MEYEROWITZ EA, Kim AY, Ard KL, Basgoz N, et al
    Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV.
    AIDS. 2020 Jun 25. doi: 10.1097/QAD.0000000000002607.
    >> Share

  274. STANKEVITZ K, Grant H, Lloyd J, Gomez GB, et al
    Oral pre-exposure prophylaxis (PrEP) continuation, measurement, and reporting: a systematic review and meta-analysis.
    AIDS. 2020 Jun 17. doi: 10.1097/QAD.0000000000002598.
    >> Share

  275. MASTRO TD, Akolo C, Shoptaw S
    Managing amphetamine use is critical to achieving HIV control.
    AIDS. 2020 Jun 16. doi: 10.1097/QAD.0000000000002611.
    >> Share

  276. BOUZIDI KEL, Jose S, Phillips AN, Pozniak A, et al
    First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelines: a cohort study.
    AIDS. 2020 Jun 8. doi: 10.1097/QAD.0000000000002603.
    >> Share

  277. VAN HALSEMA CL, Okhai H, Hill T, Sabin CA, et al
    Incidence and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the UK.
    AIDS. 2020 Jun 4. doi: 10.1097/QAD.0000000000002599.
    >> Share

  278. ZIEGLER MC, Nelde A, Weber JK, Schreitmuller CM, et al
    HIV-1-induced changes in HLA-C*03: 04-presented peptide repertoires lead to reduced engagement of inhibitory NK cell receptors.
    AIDS. 2020 Jun 4. doi: 10.1097/QAD.0000000000002596.
    >> Share

  279. SAULLE I, Ibba SV, Vittori C, Fenizia C, et al
    Sterol metabolism modulates susceptibility to HIV-1 Infection.
    AIDS. 2020 Jun 4. doi: 10.1097/QAD.0000000000002591.
    >> Share

  280. THEPPOTE AS, Carmack AE, Riedel DJ
    False positive HIV testing after T-cell receptor therapy.
    AIDS. 2020;34:1103-1105.
    >> Share

  281. LI GH, Maric D, Major EO, Nath A, et al
    Productive HIV infection in astrocytes can be established via a nonclassical mechanism.
    AIDS. 2020;34:963-978.
    >> Share

  282. BROUILLETTE MJ, Fellows LK, Mayo NE
    Efavirenz and cognition that matters.
    AIDS. 2020;34:1105-1106.
    >> Share

    May 2020
  283. KABAMI J, Balzer LB, Saddiki H, Ayieko J, et al
    Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial.
    AIDS. 2020 May 28. doi: 10.1097/QAD.0000000000002564.
    >> Share

  284. SOHN AH, Lumbiganon P, Kurniati N, Lapphra K, et al
    Determining standardized causes of death of infants, children, and adolescents living with HIV in Asia.
    AIDS. 2020 May 20. doi: 10.1097/QAD.0000000000002583.
    >> Share

  285. BAJUNIRWE F, Semakula D, Izudi J
    Risk of HIV infection among adolescent girls and young women in age-disparate relationships in sub-Saharan Africa: a systematic review and meta-analysis.
    AIDS. 2020 May 20. doi: 10.1097/QAD.0000000000002582.
    >> Share

  286. INZAULE SC, Jordan MR, Bello G, Wadonda-Kabondo N, et al
    High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly-diagnosed antiretroviral treatment naive children in sub-Saharan Africa.
    AIDS. 2020 May 20. doi: 10.1097/QAD.0000000000002580.
    >> Share

  287. CALVERT C, Marston M, Slaymaker E, Crampin AC, et al
    Direct maternal deaths attributable to HIV in the era of ART: evidence from three population-based HIV cohorts with verbal autopsy.
    AIDS. 2020 May 8. doi: 10.1097/QAD.0000000000002552.
    >> Share

  288. GOEDEL WC, Bessey S, Lurie MN, Biello KB, et al
    Projecting the impact of equity-based pre-exposure prophylaxis implementation on racial disparities in HIV incidence among men who have sex with men.
    AIDS. 2020 May 6. doi: 10.1097/QAD.0000000000002577.
    >> Share


  289. Coronary atherosclerosis characteristics in HIV-infected patients on long-term antiretroviral therapy: insights from coronary computed tomography-angiography: Erratum.
    AIDS. 2020;34:961.
    >> Share

  290. CICCULLO A, Dusina A, Lassandro AP, Borghetti A, et al
    No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine--dolutegravir.
    AIDS. 2020;34:956-957.
    >> Share

  291. COSTINIUK CT, Jenabian MA
    Reply to: Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C.
    AIDS. 2020;34:955-956.
    >> Share

  292. SANTOS ME, Protopopescu C, Zucman D, Marcellin F, et al
    Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C co-infection.
    AIDS. 2020;34:953-954.
    >> Share

  293. JOHNSTON CD, Ifeagwu KC, Siegler EL, Derry H, et al
    Elevated cardiac risk score by Atherosclerotic Cardiovascular Disease calculation is associated with albuminuria in older people living with HIV.
    AIDS. 2020;34:947-949.
    >> Share

  294. TARAMASSO L, Berruti M, Briano F, Di Biagio A, et al
    The switch from tenofovir disoproxil fumarate to tenofovir alafenamide determines weight gain in patients on rilpivirine-based regimen.
    AIDS. 2020;34:877-881.
    >> Share

  295. WALMSLEY SL, Ren M, Simon C, Clarke R, et al
    Pilot study assessing the Rotterdam Healthy Aging Score in a cohort of HIV-positive adults in Toronto, Canada.
    AIDS. 2020;34:859-867.
    >> Share

  296. GIANELLA S, Moser C, Vitomirov A, McKhann A, et al
    Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events.
    AIDS. 2020;34:849-857.
    >> Share

  297. LI Y, Altan E, Pilcher C, Hartogensis W, et al
    Semen virome of men with HIV on or off antiretroviral treatment.
    AIDS. 2020;34:827-832.
    >> Share

    April 2020
  298. SU J, Shen X, Ni Q, Zhao H, et al
    Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome.
    AIDS. 2020 Apr 17. doi: 10.1097/QAD.0000000000002553.
    >> Share

  299. LIANG J, Nosova E, Reddon H, Nolan S, et al
    Longitudinal patterns of illicit drug use, ART exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
    AIDS. 2020 Apr 16. doi: 10.1097/QAD.0000000000002551.
    >> Share

  300. WHYTE-ALLMAN SK, Hoque MT, Gilmore J, Kaul R, et al
    Drug efflux transporters and metabolic enzymes in human circulating and testicular T-cell subsets: relevance to HIV pharmacotherapy.
    AIDS. 2020 Apr 16. doi: 10.1097/QAD.0000000000002548.
    >> Share

  301. PELUSO MJ, Chen J, Munter S, Reed A, et al
    Outcomes of immunomodulatory and biologic therapy in people living with HIV: a report from two academic hospitals.
    AIDS. 2020 Apr 16. doi: 10.1097/QAD.0000000000002549.
    >> Share

  302. CROWELL CS, Williams PL, Yildirim C, Van Dyke RB, et al
    Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
    AIDS. 2020 Apr 16. doi: 10.1097/QAD.0000000000002550.
    >> Share

  303. LACEY A, Savinelli S, Barco EA, Macken A, et al
    Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV within the UCDID Cohort.
    AIDS. 2020 Apr 16. doi: 10.1097/QAD.0000000000002541.
    >> Share

  304. VITALLE J, Tarancon-Diez L, Jimenez-Leon MR, Terren I, et al
    CD300a identifies a CD4+ memory T cell subset with a higher susceptibility to HIV-1 infection.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002544.
    >> Share

  305. RAWLINGS SA, Layman L, Smith D, Scott B, et al
    Performing rapid autopsy for the interrogation of HIV reservoirs.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002546.
    >> Share

  306. DI CIACCIO M, Fressard L, Sagaon-Teyssier L, Protiere C, et al
    What are the situational and behavioral factors associated with condomless anal sex without PrEP in men who have sex with men? Results from the ANRS-IPERGAY trial.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002542.
    >> Share

  307. RAMADOSS NS, Zhao NQ, Richardson BA, Grant PM, et al
    Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002543.
    >> Share

  308. KUNISAKI KM, Nouraie M, Jensen R, Chang D, et al
    Lung function in men with and without HIV: a nested cohort substudy.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002526.
    >> Share

  309. PIGGOTT DA, Bandeen-Roche K, Mehta SH, Brown TT, et al
    Frailty transitions, inflammation and mortality among persons aging with HIV infection and injection drug use.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002527.
    >> Share

  310. MAHALE P, Ugoji C, Engels EA, Shiels MS, et al
    Cancer risk following lymphoid malignancies among HIV-infected people.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002528.
    >> Share

  311. NGUYEN N, Choi CJ, Robbins R, Korich R, et al
    Psychiatric trajectories across adolescence in perinatally HIV-exposed youth: the role of HIV infection and associations with viral load.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002529.
    >> Share

  312. PROTIERE C, Fiorentino M, Sow A, Preau M, et al
    Who are the PLWH who might refuse to participate in HIV cure-related clinical trials with treatment interruption?
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002530.
    >> Share

  313. WERTHEIM JO, Panneer N, France AM, Saduvala N, et al
    Incident infection in high-priority HIV molecular transmission clusters in the united states.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002531.
    >> Share

  314. AJIBOLA G, Moyo S, Mohammed T, Moseki S, et al
    HIV diagnostic algorithm requires confirmatory testing for initial indeterminate or positive screens in the first week of life.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002532.
    >> Share

  315. NASREDDINE R, Florence E, Vandercam B, Moutschen M, et al
    Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a belgian cohort of 4101 HIV patients.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002533.
    >> Share

  316. DAY S, Mathews A, Blumberg M, Vu T, et al
    Expanding community engagement in HIV clinical trials: a pilot study using crowdsourcing.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002534.
    >> Share

  317. SHARMA V, Bryant C, Montero M, Creegan M, et al
    Monocyte and CD4+ T cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002537.
    >> Share

  318. NJUGUNA I, Neary J, Mburu C, Black D, et al
    Clinic- and individual-level factors that influence HIV viral suppression in adolescents and young adults: a national survey in Kenya.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002538.
    >> Share

  319. TEQUE F, Ye L, Xie F, Wang J, et al
    Genetically-edited iPSCs derived from HIV-1 infected patients on therapy can give rise to immune cells resistant to HIV-1 infection.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002539.
    >> Share

  320. YE L, Wang J, Teque F, Xie F, et al
    Generation of HIV-1 infected patient's gene-edited iPSC using feeder free culture conditions.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002535.
    >> Share

  321. KRUIZE Z, Maurer I, Boeser-Nunnink BDM, Booiman T, et al
    Genetic variations in the host dependency factors ALCAM and TPST2 impact HIV-1 disease progression.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002540.
    >> Share

  322. FRIJTERS EM, Hermans LE, Wensing AMJ, Deville WLJM, et al
    Risk factors for loss to follow-up from antiretroviral therapy programmes in low- and middle-income countries: a systematic review and meta-analysis.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002523.
    >> Share

  323. MCMANUS M, Karalius B, Patel K, Persaud D, et al
    Quantitative HIV-1 specific antibodies as predictors of peripheral blood cell-associated HIV-1 DNA concentrations.
    AIDS. 2020 Apr 13. doi: 10.1097/QAD.0000000000002525.
    >> Share

  324. STREHLAU R, Paximadis M, Sherman GG, Abrams EJ, et al
    Response to Zhao and Zhou: Diagnosis of HIV infection in breastfed infants of mothers on antiretroviral therapy.
    AIDS. 2020;34:798-799.
    >> Share

  325. ZHAO H, Zhou YH
    Diagnosis of HIV infection in breastfed infants of mothers on antiretroviral therapy.
    AIDS. 2020;34:797.
    >> Share

  326. HOSODA T, Uehara Y, Kasuga T, Naito T, et al
    An HIV-infected patient with acute retinal necrosis as immune reconstitution inflammatory syndrome due to varicella-zoster virus.
    AIDS. 2020;34:795-796.
    >> Share

  327. WANG X, Boffito M, Dickinson L, Bagkeris E, et al
    Plasma nucleotide reverse transcriptase inhibitor concentration and their associations with liver and renal parameters in people living with HIV.
    AIDS. 2020;34:790-793.
    >> Share

  328. DELCHER C, Bae J, Rich SN, Klann EM, et al
    Impact of the 12 January 2010 earthquake on HIV case reporting in Haiti.
    AIDS. 2020;34:777-782.
    >> Share

  329. GRAYBILL LA, Kasaro M, Freeborn K, Walker JS, et al
    Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: a systematic review and meta-analysis.
    AIDS. 2020;34:761-776.
    >> Share

  330. COTUGNO N, Morrocchi E, Rinaldi S, Rocca S, et al
    Early antiretroviral therapy-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T-cell and B-cell memory.
    AIDS. 2020;34:669-680.
    >> Share

  331. STEWART J, Bukusi E, Celum C, Delany-Moretlwe S, et al
    Sexually transmitted infections among African women: an opportunity for combination sexually transmitted infection/HIV prevention.
    AIDS. 2020;34:651-658.
    >> Share

    March 2020
  332. TANG EC, Vittinghoff E, Philip SS, Doblecki-Lewis S, et al
    Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV pre-exposure prophylaxis.
    AIDS. 2020 Mar 19. doi: 10.1097/QAD.0000000000002522.
    >> Share

  333. PANPRADIST N, Beck IA, Ruth PS, Avila-Rios S, et al
    Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.
    AIDS. 2020 Mar 19. doi: 10.1097/QAD.0000000000002524.
    >> Share

  334. BOZZI G, Squillace N, Peri AM, Muscatello A, et al
    Immunological failure in an HIV elite controller: possible role of indirect markers of inflammation and benefit of antiretroviral therapy.
    AIDS. 2020;34:646-647.
    >> Share

  335. GREEN JA, Lum T
    Reply to the letter to the editor: antibody-mediated control of HIV-1 through an alternative pathway.
    AIDS. 2020;34:645.
    >> Share

  336. ANGELOVICH TA, Trevillyan JM, Hoy JF, Wong ME, et al
    Monocytes from men living with HIV exhibit heightened atherogenic potential despite long-term viral suppression with antiretroviral therapy.
    AIDS. 2020;34:513-518.
    >> Share

  337. BREW BJ, McArthur JC
    'A man is as old as his arteries' (attributed to Thomas Sydenham, the English Hippocrates).
    AIDS. 2020;34:637-639.
    >> Share

  338. ALAEI K, Zaidi H
    A centralized or decentralized approach when it comes to socially stigmatized health concerns in conservative social settings.
    AIDS. 2020;34:647-649.
    >> Share

  339. KUMAR RN, Stosor V
    Organ Transplantation in Persons with HIV.
    AIDS. 2020 Mar 11. doi: 10.1097/QAD.0000000000002518.
    >> Share

  340. BEER L, Tie Y, Smith DK, Fagan JL, et al
    Reported Preexposure Prophylaxis (PrEP) Use Among Male Sex Partners of HIV-Positive Men-2016-2018.
    AIDS. 2020 Mar 11. doi: 10.1097/QAD.0000000000002517.
    >> Share

  341. HENTZIEN M, Cuzin L, Raffi F, Jacomet C, et al
    Factors associated with psoriasis in a French Nationwide HIV cohort: the independent role of HLA-B*57: 01.
    AIDS. 2020 Mar 11. doi: 10.1097/QAD.0000000000002519.
    >> Share

  342. LAURENCE J, Elhadad S, Gostynska S, Yu Z, et al
    HIV protease inhibitor ritonavir induces renal fibrosis and dysfunction: role of platelet-derived TGF-beta1 and intervention via anti-oxidant pathways.
    AIDS. 2020 Mar 11. doi: 10.1097/QAD.0000000000002516.
    >> Share

  343. CHELICO L, King A, Ticknor J, McDonald M, et al
    Perspectives of Saskatchewan researchers and community members on HIV-1 strains circulating in Saskatchewan.
    AIDS. 2020 Mar 3. doi: 10.1097/QAD.0000000000002515.
    >> Share

  344. SENONER T, Dichtl W, Feuchtner GM
    The perivascular fat gradient in HIV-infected patients.
    AIDS. 2020;34:490-491.
    >> Share

  345. WEST HW, Antoniades C
    The Fat Attenuation Index in HIV-infected patients.
    AIDS. 2020;34:489-490.
    >> Share

  346. WOOD BR
    Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket).
    AIDS. 2020;34:481-482.
    >> Share

  347. STUART RM, Kelly SL, Martin-Hughes R, Wilson DP, et al
    Potential health gains in West and Central Africa through savings from lower cost HIV treatment.
    AIDS. 2020;34:439-446.
    >> Share

  348. ALGHAMDI A, Hempel A, Heendeniya A, Clifford-Rashotte M, et al
    HIV postexposure prophylaxis-in-pocket: long-term follow-up of individuals with low-frequency, high-risk HIV exposures.
    AIDS. 2020;34:433-437.
    >> Share

  349. RIAL-CRESTELO D, Sepulveda MA, Gonzalez-Gasca FJ, Geijo-Martinez P, et al
    Does fibrosis really regress in HIV/hepatitis C virus co-infected patients after treatment with direct antiviral agents?
    AIDS. 2020;34:427-432.
    >> Share

  350. JAMES CW, Szabo S, Kahal D, Goldstein ND, et al
    The effect of multivitamins and polyvalent cations on virologic suppression with integrase strand transfer inhibitors.
    AIDS. 2020;34:487-489.
    >> Share

  351. VILLINGER F
    In-vivo use of SIVmac239 with a reversing stop codon in the SIV nef gene.
    AIDS. 2020;34:487.
    >> Share

    February 2020
  352. XIA Q, Lim S, Wu B, Forgione LA, et al
    Estimating the probability of diagnosis within one year of HIV acquisition.
    AIDS. 2020 Feb 20. doi: 10.1097/QAD.0000000000002510.
    >> Share

  353. DIRAJLAL-FARGO S, Albar Z, Bowman E, Labbato D, et al
    Increased monocyte and T-cell activation in treated HIV+ ugandan children: associations with gut alteration and HIV factors.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002505.
    >> Share

  354. FIELDS JA, Swinton MK, Soontornniyomkij B, Carson A, et al
    Beta amyloid levels in CSF of HIV-infected people vary by exposure to antiretroviral therapy.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002506.
    >> Share

  355. SHIPEOLU L, Sampsel K, Reeves A, Blaskovits F, et al
    HIV nonoccupational postexposure prophylaxis (nPEP) for sexual assault cases: a three-year investigation.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002507.
    >> Share

  356. AVDOSHINA V, Mahoney M, Gilmore SF, Wenzel ED, et al
    HIV influences microtubule associated protein-2: Potential marker of HIV-associated neurocognitive disorders.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002509.
    >> Share

  357. LI GH, Maric D, Major EO, Nath A, et al
    Productive HIV infection in astrocytes can be established via a non-classical mechanism.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002512.
    >> Share

  358. CHASIMPHA SJD, Mclean EM, Dube A, Mccormack V, et al
    Assessing the validity of and factors that influence accurate self-reporting of HIV status after testing: a population-based study.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002513.
    >> Share

  359. SALLEH NAM, Van Draanen J, Nosova E, Barrios R, et al
    Material security and adherence to antiretroviral therapy (ART) among HIV-positive people who use illicit drugs.
    AIDS. 2020 Feb 17. doi: 10.1097/QAD.0000000000002501.
    >> Share

  360. HABER NA, Lesko CR, Fox MP, Powers KA, et al
    Limitations of the UNAIDS 90-90-90 metrics: a simulation-based comparison of cross-sectional and longitudinal metrics for the HIV care continuum.
    AIDS. 2020 Feb 10. doi: 10.1097/QAD.0000000000002502.
    >> Share

  361. ZAUNDERS J, Munier CML, McGuire H, Law H, et al
    Mapping the extent of heterogeneity of human CCR5+ CD4 T-cells in peripheral blood and lymph nodes.
    AIDS. 2020 Feb 10. doi: 10.1097/QAD.0000000000002503.
    >> Share

  362. EDWARDS JK, Arimi P, Ssengooba F, Herce M, et al
    Improving HIV outreach testing yield at cross-border venues in East Africa.
    AIDS. 2020 Feb 10. doi: 10.1097/QAD.0000000000002500.
    >> Share

  363. NISHIJIMA T, Inaba Y, Kawasaki Y, Tsukada K, et al
    Mortality and causes of death in people living with HIV in the era of combination antiretroviral therapy compared with the general population in Japan.
    AIDS. 2020 Feb 6. doi: 10.1097/QAD.0000000000002498.
    >> Share

  364. TARAMASSO L, Berruti M, Briano F, di Biagio A, et al
    The switch from TDF to TAF determines weight gain in patients on rilpivirine-based regimen.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002496.
    >> Share

  365. LI Y, Altan E, Pilcher C, Hartogensis W, et al
    Semen virome of men with HIV on or off anti-retroviral treatment.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002497.
    >> Share

  366. COHEN J, Pepperrell T, Francois Venter WD
    The same lesson over and over: drugs alone will not get us to 90-90-90.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002494.
    >> Share

  367. MCCAUSLAND MR, Lebron AC, Pilch-Cooper HA, Howell S, et al
    Toll-like receptor distribution in colonic epithelium and lamina propria is disrupted in HIV viremic, immune success and failure.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002499.
    >> Share

  368. VENDRAME E, Seiler C, Ranganath T, Zhao NQ, et al
    TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002488.
    >> Share

  369. STADER F, Decosterd L, Stoeckle M, Cavassini M, et al
    Aging does not impact drug-drug interaction magnitudes with antiretrovirals: a Swiss HIV Cohort Study.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002489.
    >> Share

  370. YANG CT, Toh HS, Liao CT, Kuo S, et al
    Early scale-up of antiretroviral therapy at diagnosis for reducing economic burden of cardiometabolic disease in HIV-infected population.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002490.
    >> Share

  371. SIANGPHOE U, Archer KJ, Nguyen C, Lee KR, et al
    Associations of antiretroviral therapy and comorbidities with neurocognitive outcomes in HIV-1 infected patients.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002491.
    >> Share

  372. JOHNSTON CD, Ifeagwu KC, Siegler EL, Derry H, et al
    Elevated cardiac risk score by ASCVD calculation is associated with albuminuria in older people living with HIV.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002492.
    >> Share

  373. GRAYBILL LA, Kasaro M, Freeborn K, Walker JS, et al
    Incident HIV among pregnant and breastfeeding women in sub-Saharan Africa: a systematic review and meta-analysis.
    AIDS. 2020 Feb 3. doi: 10.1097/QAD.0000000000002487.
    >> Share

  374. COTUGNO N, Morrocchi E, Rinaldi S, Rocca S, et al
    Early ART-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T and B cell memory.
    AIDS. 2020 Feb 3. doi: 10.1097/QAD.0000000000002485.
    >> Share

  375. WALMSLEY SL, Ren M, Simon C, Clarke R, et al
    Pilot study assessing the rotterdam healthy aging score in a cohort of human immunodeficiency virus positive adults in Toronto, Canada.
    AIDS. 2020 Feb 3. doi: 10.1097/QAD.0000000000002493.
    >> Share


  376. Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV: Erratum.
    AIDS. 2020;34:333.
    >> Share

  377. ETCHEVERRY-RUFINO F, Lucero C, Lopez-Ceron M, Alenar-Gelabert Y, et al
    Local barrier dysfunction identified by confocal laser endomicroscopy predicts bacterial translocation in HIV infection.
    AIDS. 2020;34:328-331.
    >> Share

  378. CACHAY E
    Do we need to address stigma and mistrust to facilitate hepatitis C elimination among people living with HIV?
    AIDS. 2020;34:325-331.
    >> Share

  379. PEPPERRELL T, Venter WDF, Moorhouse M, McCann K, et al
    Time to rethink endpoints for new clinical trials of antiretrovirals? Long-term re-suppression of HIV RNA with integrase inhibitors.
    AIDS. 2020;34:321-324.
    >> Share

  380. GUARALDI G, Milic J
    Vitamin E as a 'bridge' therapy for nonalcoholic steatohepatits in HIV: what is waiting on the other side of the bridge?
    AIDS. 2020;34:317-319.
    >> Share


  381. All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas.
    AIDS. 2020;34:277-289.
    >> Share

  382. LIN KS, Win S, Nyein PP
    Drug-induced immune hemolytic anemia because of efavirenz: a case report.
    AIDS. 2020;34:326-328.
    >> Share

    January 2020
  383. JAMIESON L, Gomez GB, Rebe K, Brown B, et al
    The impact of self-selection based on HIV risk on the cost-effectiveness of pre-exposure prophylaxis in South Africa.
    AIDS. 2020 Jan 30. doi: 10.1097/QAD.0000000000002486.
    >> Share

  384. GIANELLA S, Moser C, Vitomirov A, McKhann A, et al
    Presence of asymptomatic CMV and EBV DNA in blood of persons with HIV starting antiretroviral therapy are associated with non-AIDS clinical events.
    AIDS. 2020 Jan 30. doi: 10.1097/QAD.0000000000002484.
    >> Share

  385. WANG X, Boffito M, Dickinson L, Bagkeris E, et al
    Plasma NRTI concentration and their associations with liver and renal parameters in people living with HIV.
    AIDS. 2020 Jan 30. doi: 10.1097/QAD.0000000000002479.
    >> Share

  386. PHILLIPS TK, Orrell C, Brittain K, Zerbe A, et al
    Measuring retention in HIV care: the impact of data sources and definitions using routine data in South Africa.
    AIDS. 2020 Jan 30. doi: 10.1097/QAD.0000000000002478.
    >> Share

  387. GIRON LB, Papasavvas E, Azzoni L, Yin X, et al
    Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint.
    AIDS. 2020 Jan 17. doi: 10.1097/QAD.0000000000002476.
    >> Share

  388. TASKER C, Pizutelli V, Lo Y, Ramratnam B, et al
    Depot medroxyprogesterone acetate (Depo-Provera) administration increases cervical CCR5+CD4+ T cells and induces immunosuppressive milieu at the cervicovaginal mucosa: a 3-month longitudinal study.
    AIDS. 2020 Jan 16. doi: 10.1097/QAD.0000000000002475.
    >> Share

  389. HORSBURGH BA, Lee E, Hiener B, Eden JS, et al
    High levels of genetically-intact HIV in HLA-DR+ memory T-cells indicates their value for reservoir studies.
    AIDS. 2020 Jan 6. doi: 10.1097/QAD.0000000000002465.
    >> Share

  390. SHROUFI A, Van Cutsem G, Cambiano V, Bansi-Matharu L, et al
    HIV viral load algorithm: what are the needs in the field?: authors' response.
    AIDS. 2020;34:160-162.
    >> Share

  391. MASSAD LS, Xie X, Minkoff H, Kassaye S, et al
    Longitudinal assessment of abnormal Papanicolaou test rates among women with HIV.
    AIDS. 2020;34:73-80.
    >> Share

  392. GRAS J, Mahjoub N, Charreau I, Cotte L, et al
    Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxis.
    AIDS. 2020;34:47-52.
    >> Share

  393. SVIRIDOV D, Mukhamedova N, Makarov AA, Adzhubei A, et al
    Comorbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality.
    AIDS. 2020;34:1-13.
    >> Share

    December 2019
  394. KR KWAA A, Garliss CC, Ritter KD, Laird GM, et al
    Elite suppressors have low frequencies of intact HIV-1 proviral DNA.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002474.
    >> Share

  395. SALOU M, Butel C, Comlan AS, Konou AA, et al
    Challenges of scale-up to Dolutegravir based regimens in sub-Saharan Africa: a case study in Togo.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002470.
    >> Share

  396. PAUL RH, Cho KS, Belden AC, Mellins CA, et al
    Machine learning classification of neurocognitive performance in children with perinatal HIV initiating de novo antiretroviral therapy.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002471.
    >> Share

  397. DELCHER C, Bae J, Rich SN, Klann EM, et al
    Impact of the January 12, 2010 earthquake on HIV case reporting in Haiti: an interrupted time series analysis.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002466.
    >> Share

  398. ALBERT AYK, Elwood C, Wagner EC, Pakzad Z, et al
    Investigation of Factors Associated with Spontaneous Preterm Birth in Pregnant Women Living with HIV.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002464.
    >> Share

  399. STEWART J, Bukusi E, Celum C, Delany-Moretlwe S, et al
    Sexually transmitted infections among African women: an underrecognized epidemic and an opportunity for combination STI/HIV prevention.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002472.
    >> Share

  400. YE J, Hao M, Xing H, Zhang F, et al
    Transmitted HIV drug resistance among individuals with newly diagnosed HIV infection: A multicenter observational study.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002468.
    >> Share

  401. REITSEMA M, Van Hoek AJ, Van Der Loeff MS, Hoornenborg E, et al
    Pre-exposure prophylaxis for msm in the netherlands: impact on hiv and n.gonorrhoeae transmission and cost-effectiveness.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002469.
    >> Share

  402. CARR M, Richardson R, Tong W, Bloch M, et al
    Switch from tenofovir DF to raltegravir is not associated with weight gain over 96 weeks.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002473.
    >> Share

  403. MAHEU-GIROUX M, Jahn A, Kalua T, Mganga A, et al
    HIV surveillance based on routine testing data from antenatal clinics in Malawi (2011-2018): measuring and adjusting for bias from imperfect testing coverage.
    AIDS. 2019;33 Suppl 3:S295-S302.
    >> Share

  404. STOVER J, Glaubius R, Mofenson L, Dugdale CM, et al
    Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels.
    AIDS. 2019;33 Suppl 3:S227-S234.
    >> Share

  405. TRICKEY A, van Sighem A, Stover J, Abgrall S, et al
    Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings.
    AIDS. 2019;33 Suppl 3:S271-S281.
    >> Share

  406. EATON JW, Brown T, Puckett R, Glaubius R, et al
    The Estimation and Projection Package Age-Sex Model and the r-hybrid model: new tools for estimating HIV incidence trends in sub-Saharan Africa.
    AIDS. 2019;33 Suppl 3:S235-S244.
    >> Share

  407. BESSON C, Noel N, Lancar R, Prevot S, et al
    HCV or HBV coinfection and lymphoma risk in people living with HIV.
    AIDS. 2019 Dec 10. doi: 10.1097/QAD.0000000000002461.
    >> Share

  408. ORKIN C, Eron JJ, Rockstroh J, Podzamczer D, et al
    Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients.
    AIDS. 2019 Dec 10. doi: 10.1097/QAD.0000000000002463.
    >> Share

  409. WOLDESENBET SA, Kufa T, Barron P, Chirombo BC, et al
    Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa: a national cross-sectional survey.
    AIDS. 2019 Dec 9. doi: 10.1097/QAD.0000000000002457.
    >> Share

  410. ANGELOVICH TA, Trevillyan JM, Hoy JF, Wong ME, et al
    Monocytes from men living with HIV exhibit heightened atherogenic potential despite long term viral suppression with ART.
    AIDS. 2019 Dec 5. doi: 10.1097/QAD.0000000000002460.
    >> Share

  411. BRICENO O, Chavez-Torres M, Peralta-Prado A, Garrido-Rogriguez D, et al
    Associations between recent thymic emigrants and CD4+ T cell recovery after short-term antiretroviral therapy initiation.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002458.
    >> Share

  412. ASCHER SB, Scherzer R, Estrella MM, Shigenaga J, et al
    HIV pre-exposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002456.
    >> Share

  413. XIA Q, Wertheim JO, Braunstein SL, Misra K, et al
    Use of molecular HIV surveillance data and predictive modeling to prioritize persons for transmission-reduction interventions.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002452.
    >> Share

  414. KREBS E, Zang X, Enns B, Min JE, et al
    The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002455.
    >> Share

  415. YOUNG PW, Zielinski-Gutierrez E, Wamicwe J, Mukui I, et al
    Use of viral load to improve survey estimates of known HIV-positive status and antiretroviral treatment coverage.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002453.
    >> Share

  416. KAKKAR F, Lee T, Hawkes MT, Brophy J, et al
    Challenges to achieving and maintaining viral suppression among Canadian children living with perinatal HIV infection in the Early Pediatric Initiation Canada Child Cure Cohort.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002454.
    >> Share

  417. MCCRARY AW, Nyandiko W, Ellis AM, Chakraborty H, et al
    Early cardiac dysfunction in children and young adults with perinatally acquired HIV.
    AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002445.
    >> Share


  418. Women, incarceration and HIV: a systematic review of HIV treatment access, continuity of care and health outcomes across incarceration trajectories: Erratum.
    AIDS. 2019;33:2451.
    >> Share

  419. DEL PUENTE F, Pontali E, Torresin A, Cassola G, et al
    Long-term safety and efficacy of dolutegravir and unboosted atazanavir among experienced HIV-infected adults.
    AIDS. 2019;33:2446-2447.
    >> Share

  420. BARAKAT E, Oren NC, Vaysberg A
    Symptomatic cerebrospinal fluid HIV escape syndrome in a patient on highly active antiretroviral therapy and suppressed plasma viral load.
    AIDS. 2019;33:2444-2446.
    >> Share

  421. FEITERNA-SPERLING C, Kruger R, Amara A, Khoo S, et al
    Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1-infected woman.
    AIDS. 2019;33:2443-2444.
    >> Share

  422. MAZZITELLI M, Milinkovic A, Pereira B, Palmer J, et al
    Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV.
    AIDS. 2019;33:2439-2441.
    >> Share

  423. MCHEMBERE W, Agaya J, Yuen CM, Okelloh D, et al
    High yield of new HIV diagnoses during active case-finding for tuberculosis.
    AIDS. 2019;33:2431-2435.
    >> Share

  424. OTIENO G, Whiteside YO, Achia T, Kwaro D, et al
    Decreased HIV-associated mortality rates during scale-up of antiretroviral therapy, 2011-2016.
    AIDS. 2019;33:2423-2430.
    >> Share

  425. MUPFUMI L, Moyo S, Shin SS, Wang Q, et al
    High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.
    AIDS. 2019;33:2415-2422.
    >> Share

  426. VENKATESH KK, Farhad M, Fenton T, Moodley D, et al
    Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
    AIDS. 2019;33:2403-2413.
    >> Share

  427. THIN K, Frederix K, McCracken S, Letsie M, et al
    Progress toward HIV epidemic control in Lesotho.
    AIDS. 2019;33:2393-2401.
    >> Share

  428. MILINKOVIC A, Berger F, Arenas-Pinto A, Mauss S, et al
    Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back.
    AIDS. 2019;33:2387-2391.
    >> Share

  429. CARLUCCI JG, Liu Y, Clouse K, Vermund SH, et al
    Attrition of HIV-positive children from HIV services in low and middle-income countries.
    AIDS. 2019;33:2375-2386.
    >> Share

  430. KIM-CHANG JJ, Donovan K, Loop MS, Hong S, et al
    Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV.
    AIDS. 2019;33:2363-2374.
    >> Share

  431. YUAN N, Scherzer R, Tanriverdi K, Martin J, et al
    MicroRNA biomarkers associated with type 1 myocardial infarction in HIV-positive individuals.
    AIDS. 2019;33:2351-2361.
    >> Share

  432. LAMPE FC, Rodger AJ, Burman W, Grulich A, et al
    Impact of early antiretroviral treatment on sexual behaviour: a randomised comparison.
    AIDS. 2019;33:2337-2350.
    >> Share

  433. PALELLA FJ, Hart R, Armon C, Tedaldi E, et al
    Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care.
    AIDS. 2019;33:2327-2335.
    >> Share

  434. DONALDSON MA, Campbell AR, Albert AY, Borhani M, et al
    Comorbidity and polypharmacy among women living with HIV in British Columbia.
    AIDS. 2019;33:2317-2326.
    >> Share

  435. ANDERSON AM, Perez-Santiago J, Zheng Z, Huang E, et al
    Better executive function is independently associated with full HIV suppression during combination therapy.
    AIDS. 2019;33:2309-2316.
    >> Share

  436. COUNCIL OD, Ruone S, Mock PA, Khalil G, et al
    HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis.
    AIDS. 2019;33:2299-2307.
    >> Share

  437. SAINZ T, Serrano-Villar S, Mann S, Ma ZM, et al
    Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy.
    AIDS. 2019;33:2289-2298.
    >> Share

  438. COSTINIUK CT, Jenabian MA
    Cannabinoids and inflammation: implications for people living with HIV.
    AIDS. 2019;33:2273-2288.
    >> Share

  439. JOSEPH SB, Trunfio M, Kincer LP, Calcagno A, et al
    What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
    AIDS. 2019;33 Suppl 2:S171-S179.
    >> Share

  440. BREW BJ, Barnes SL
    The impact of HIV central nervous system persistence on pathogenesis.
    AIDS. 2019;33 Suppl 2:S113-S121.
    >> Share

  441. WINSTON A, Antinori A, Cinque P, Fox HS, et al
    Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS.
    AIDS. 2019;33 Suppl 2:S107-S111.
    >> Share

  442. HSU DC, Silsorn D, Inthawong D, Kuncharin Y, et al
    Impact of analytical treatment interruption on the central nervous system in a simian-HIV model.
    AIDS. 2019;33 Suppl 2:S189-S196.
    >> Share

  443. ABREU C, Shirk EN, Queen SE, Beck SE, et al
    Brain macrophages harbor latent, infectious simian immunodeficiency virus.
    AIDS. 2019;33 Suppl 2:S181-S188.
    >> Share

  444. MASTRANGELO A, Turrini F, de Zan V, Caccia R, et al
    Symptomatic cerebrospinal fluid escape.
    AIDS. 2019;33 Suppl 2:S159-S169.
    >> Share

  445. HENDERSON LJ, Johnson TP, Smith BR, Reoma LB, et al
    Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy.
    AIDS. 2019;33 Suppl 2:S145-S157.
    >> Share

  446. SPUDICH S, Peterson J, Fuchs D, Price RW, et al
    Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence.
    AIDS. 2019;33 Suppl 2:S135-S144.
    >> Share

  447. SPUDICH S, Clements JE
    HIV persistence in the central nervous system during antiretroviral therapy: evidence and implications.
    AIDS. 2019;33 Suppl 2:S103-S106.
    >> Share

    November 2019
  448. POIZOT-MARTIN I, Lions C, Cheret A, Rey D, et al
    Kaposi sarcoma in people living with HIV: incidence and associated factors in the French DAT'AIDS cohort between 2010 and 2015.
    AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002450.
    >> Share

  449. VEIL R, Poizot-Martin I, Reynes J, Goujard C, et al
    Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection.
    AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002447.
    >> Share

  450. REDDY K, Kelly C, Brown ER, Jeenarain N, et al
    Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities.
    AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002451.
    >> Share

  451. TRICKEY A, van Sighem A, Stover J, Abgrall S, et al
    Parameter estimates for trends and patterns of excess mortality among persons on ART in high-income european settings.
    AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002387.
    >> Share

  452. MAHEU-GIROUX M, Marsh K, Doyle C, Godin A, et al
    National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the "first 90" from program and survey data.
    AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002386.
    >> Share

  453. MEYERS T, Samson P, Acosta EP, Moye J, et al
    Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis.
    AIDS. 2019;33:2197-2203.
    >> Share

  454. THORNHILL JP, Lynch KD, Skelton JK, Dorner M, et al
    Vedolizumab use and the associations between alpha4beta7 expression and HIV reservoir in the gut during treated primary HIV infection.
    AIDS. 2019;33:2268-2271.
    >> Share

  455. DUARTE F, Soares MA
    Simplified two-drug antiretroviral HIV treatment: novel data and expected impact.
    AIDS. 2019;33:2266-2268.
    >> Share

  456. TSUKAMOTO T
    Spontaneous HIV controllers might be the key to prevent accelerated immunosenescence of effector CD8+ T cells.
    AIDS. 2019;33:2253-2255.
    >> Share

  457. WILLIAMS DW, Elahi S
    Profound immune consequences for young adults infected with HIV perinatally or during childhood: a cautionary tale regarding adherence to antiretroviral therapy.
    AIDS. 2019;33:2251-2252.
    >> Share

  458. UMLAUF A, Soontornniyomkij B, Sundermann EE, Gouaux B, et al
    Risk of developing cerebral beta-amyloid plaques with posttranslational modification among HIV-infected adults.
    AIDS. 2019;33:2157-2166.
    >> Share

  459. HENRIQUEZ S, Lecuroux C, Bitu M, Avettand-Fenoel V, et al
    The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients.
    AIDS. 2019;33:2137-2147.
    >> Share

  460. RIAL-CRESTELO D, Sepulveda MA, Gonzalez-Gasca FJ, Geijo-Martinez P, et al
    Does fibrosis really regress in HIV/HCV co-infected patients after treatment with direct-antiviral agents?
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002433.
    >> Share

  461. MORANGUINHO I, Borrego P, Goncalves F, Gomes P, et al
    Genotypic resistance profiles of HIV-2 infected patients from Cape Verde failing first-line antiretroviral therapy.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002431.
    >> Share

  462. HOFFMAN RM, Balakasi K, Bardon AR, Siwale Z, et al
    Eligibility for differentiated models of HIV treatment service delivery: an estimate from Malawi and Zambia.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002435.
    >> Share

  463. ALGHAMDI A, Hempel A, Heendeniya A, Clifford-Rashotte M, et al
    HIV post-exposure prophylaxis-in-pocket ("PIP"): long-term follow-up of individuals with low-frequency, high-risk HIV exposures.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002441.
    >> Share

  464. JAMES KS, Trumble I, Clohosey ML, Moeser M, et al
    Measuring the contribution of gammadelta T cells to the persistent HIV reservoir.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002434.
    >> Share

  465. LIPSHULTZ SE, Sasaki N, Thompson B, Eidem BW, et al
    Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002443.
    >> Share

  466. ELLER MA, Hong T, Creegan M, Nau ME, et al
    Activated PD-1+ CD4 T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002432.
    >> Share

  467. LUPIA T, Milia MG, Atzori C, Gianella S, et al
    Presence of EBV DNA in Cerebrospinal Fluid is Associated with Greater HIV RNA and Inflammation.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002442.
    >> Share

  468. EATON JW, Brown T, Puckett R, Glaubius R, et al
    EPP-ASM and the r-hybrid model: new tools for estimating HIV incidence trends in sub-Saharan Africa.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002437.
    >> Share

  469. CASE KK, Johnson LF, Mahy M, Marsh K, et al
    Summarizing the results and methods of the 2019 UNAIDS HIV estimates.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002440.
    >> Share

  470. KALLIANPUR KJ, Jahanshad N, Sailasuta N, Benjapornpong K, et al
    Regional brain volumetric changes despite two years of treatment initiated during acute HIV infection.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002436.
    >> Share

  471. PURYEAR SB, Balzer LB, Ayieko J, Kwarisiima D, et al
    Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002427.
    >> Share

  472. LE BERRE AP, Fama R, Sassoon SA, Zahr NM, et al
    Cognitive impairment severity in relation to signs of subclinical Wernicke's encephalopathy in HIV and alcoholism comorbidity.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002428.
    >> Share

  473. MENEZES EGM, Ramallho J, Bucovsky M, Shane E, et al
    Serum extracellular vesicles expressing bone activity markers associate with bone loss after HIV antiretroviral therapy.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002430.
    >> Share

  474. PEPPERRELL T, Venter WDF, Moorhouse M, McCann K, et al
    Time to rethink endpoints for new antiretroviral regimen registration? HIV RNA re-suppression in the ADVANCE trial.
    AIDS. 2019 Nov 12. doi: 10.1097/QAD.0000000000002422.
    >> Share

  475. GRAY DM, Wedderburn CJ, MacGinty RP, McMillan L, et al
    Impact of HIV and antiretroviral drug exposure on lung growth and function over 2 years in an African Birth Cohort.
    AIDS. 2019 Nov 11. doi: 10.1097/QAD.0000000000002444.
    >> Share

  476. SAFARPOUR H, Cevik M, Zarean M, Barac A, et al
    Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV: A systematic review and meta-analysis.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002424.
    >> Share

  477. VIZCARRA P, Vivancos MJ, Perez-Elias MJ, Moreno A, et al
    Weight gain in people living with HIV switched to dual therapy: changes in body fat mass.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002421.
    >> Share

  478. VAN BILSEN WPH, Boyd A, van der Loeff MFS, Davidovich U, et al
    Diverging trends in incidence of HIV versus other sexually transmitted infections in HIV-negative men who have sex with men (MSM) in Amsterdam.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002417.
    >> Share

  479. TENORE SB, Avelino-Silva VI, Costa PR, Franco LM, et al
    Immune effects of Lactobacillus casei Shirota in treated HIV-infected patients with poor CD4+ T cell recovery: a randomized trial.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002420.
    >> Share

  480. MAFFEI VJ, Ferguson TF, Brashear MM, Mercante DE, et al
    Lifetime alcohol use among persons living with hiv is associated with frailty.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002426.
    >> Share

  481. NDUAGUBA SO, Barner JC, Ford KH, Lawson KA, et al
    Association between quality of care indicators for HIV infection and healthcare resource utilization and costs.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002418.
    >> Share

  482. STUART RM, Kelly SL, Martin-Hughes R, Wilson DP, et al
    Potential health gains among key populations in West and Central Africa through savings from lower-cost HIV treatment.
    AIDS. 2019 Nov 9. doi: 10.1097/QAD.0000000000002419.
    >> Share

  483. BRETON G, Laborde-Balen G, Guilavogui F, Karemangino S, et al
    HIV viral load algorithm, what are the needs in the field?
    AIDS. 2019 Nov 5. doi: 10.1097/QAD.0000000000002382.
    >> Share

  484. UNDERWOOD ML, Nguyen T, Uebelhoer LS, Kunkel LE, et al
    Altered monocyte phenotype and dysregulated innate cytokine responses among people living with HIV and opioid-use disorder.
    AIDS. 2019 Nov 4. doi: 10.1097/QAD.0000000000002416.
    >> Share

  485. BOCCHER-LATTIMORE D, Millery M, McKinnon K, Li M, et al
    Workforce development needs in HIV care: a response to mental health and HIV/AIDS: the need for an integrated response.
    AIDS. 2019;33:2109-2110.
    >> Share

  486. OLAKUNDE BO, Pharr JR, Adeyinka DA, Danquah P, et al
    HIV-related risk behaviors and testing among adolescent gay and bisexual boys in the United States.
    AIDS. 2019;33:2107-2109.
    >> Share

  487. MARTINEZ-REBOLLAR M, Pascual PP, de la Mora L, Londono MC, et al
    Contributing awareness of autoimmune hepatitis in HIV patients.
    AIDS. 2019;33:2103-2105.
    >> Share

  488. TEASDALE CA, Yuengling KA, Mutiti A, Arpadi S, et al
    Delays in fast track antiretroviral therapy initiation and reasons for not starting treatment among eligible children in Eastern Cape, South Africa.
    AIDS. 2019;33:2099-2101.
    >> Share

  489. MEYERS DJ, Cole MB, Rahman M, Lee Y, et al
    The association of provider and practice factors with HIV antiretroviral therapy adherence.
    AIDS. 2019;33:2081-2089.
    >> Share

  490. BRENNAN AT, Berry KM, Rosen S, Stokes A, et al
    Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa.
    AIDS. 2019;33:2049-2059.
    >> Share

    October 2019
  491. SEBASTIANI G, Saeed S, Lebouche B, de Pokomandy A, et al
    Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients.
    AIDS. 2019 Oct 16. doi: 10.1097/QAD.0000000000002412.
    >> Share

  492. SUTCLIFFE CG, Drogt CS, van Dijk JH, Hamangaba F, et al
    Timing of and factors associated with HIV disclosure among perinatally infected children in rural Zambia.
    AIDS. 2019 Oct 16. doi: 10.1097/QAD.0000000000002411.
    >> Share

  493. FOSTER C, Ayers S, Mcdonald S, Frize G, et al
    Clinical outcomes post transition to adult services in young adults with perinatally acquired HIV infection: mortality, retention in care, and viral suppression.
    AIDS. 2019 Oct 16. doi: 10.1097/QAD.0000000000002410.
    >> Share

  494. AIZIRE J, Sikorskii A, Ogwang LW, Kawalazira R, et al
    Decreased growth among antiretroviral drug and HIV exposed uninfected versus unexposed children in Malawi and Uganda.
    AIDS. 2019 Oct 12. pii: 00002030-900000000-00001.
    >> Share

  495. CHAISSON LH, Saraceni V, Cohn S, Seabrook D, et al
    CD4 count stratification to guide tuberculosis preventive therapy for people living with HIV.
    AIDS. 2019 Oct 11. doi: 10.1097/QAD.0000000000002398.
    >> Share

  496. GANDHI M, Wang G, King R, Rodrigues WC, et al
    Development and Validation of the First Point-of-Care Assay to Objectively Monitor Adherence to HIV Treatment and Prevention in Real-Time in Routine Settings.
    AIDS. 2019 Oct 11. doi: 10.1097/QAD.0000000000002395.
    >> Share

  497. DEL AMO J, Jarrin I
    All-cause mortality after ART initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas.
    AIDS. 2019 Oct 11. doi: 10.1097/QAD.0000000000002399.
    >> Share

  498. LESOSKY M, Raboud JM, Glass T, Brummel SS, et al
    Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa: a simulation study.
    AIDS. 2019 Oct 11. doi: 10.1097/QAD.0000000000002400.
    >> Share

  499. LI Y, Liu H, Ramadhani HO, Ndembi N, et al
    Genetic Clustering Analysis for HIV Infection among Men Who Have Sex with Men in Nigeria: implications for intervention.
    AIDS. 2019 Oct 11. doi: 10.1097/QAD.0000000000002409.
    >> Share

  500. MACATANGAY BJC, Gandhi RT, Brad Jones R, Mcmahon DK, et al
    PD-1HI T cells are associated with lower hiv-specific immune responses despite long-term antiretroviral therapy.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002406.
    >> Share

  501. CHANG K, Premeaux TA, Cobigo Y, Milanini B, et al
    Plasma inflammatory biomarkers link to diffusion tensor imaging metrics in virally suppressed HIV-infected individuals.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002404.
    >> Share

  502. ZHANG HQ, Xia P, Huang HH, Zhang C, et al
    CD4+CD19+ conjugates favor HIV-1 infection and latency during chronic HIV-1 infection.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002402.
    >> Share

  503. COUNCIL OD, Ruone S, Mock PA, Khalil G, et al
    HIV-1 genetic diversity to estimate time of infection and infer adherence to pre-exposure prophylaxis.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002390.
    >> Share

  504. HSU DC, Ma YF, Narwan A, Rahalkar S, et al
    Plasma tissue factor and immune activation are associated with carotid intima-media thickness progression in treated HIV infection.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002389.
    >> Share

  505. FOGEL JM, Sivay MV, Cummings V, Wilson EA, et al
    HIV drug resistance in a cohort of HIV-infected men who have sex with men in the United States.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002394.
    >> Share

  506. MORAN CA, Southmayd G, Devireddy CM, Quyyumi AA, et al
    Clinical and procedural characteristics of persons living with HIV presenting with acute coronary syndrome.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002393.
    >> Share

  507. OGBUOJI O, Geldsetzer P, Wong C, Khan S, et al
    Impact of immediate initiation of antiretroviral therapy on HIV patient satisfaction: a stepped-wedge cluster-randomized controlled trial.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002392.
    >> Share

  508. MEZA G, Exposito A, Royo JL, Ruiz-Garcia C, et al
    Association of CR2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 Vaccine.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002401.
    >> Share

  509. MAZZITELLI M, Milinkovic A, Pereira B, Palmer J, et al
    Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002403.
    >> Share

  510. BARRY PA, Deere JD, Yue Y, Chang WW, et al
    Cytomegalovirus (CMV)-Vectored vaccines for HIV and other pathogens.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002396.
    >> Share

  511. ABBAR B, Baron M, Katlama C, Marcelin AG, et al
    Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002397.
    >> Share

  512. LIU L, Dai L, Yao J, Pan P, et al
    Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naive individuals in a tertiary care hospital in Beijing, China.
    AIDS. 2019;33:1945-1947.
    >> Share


  513. Strong sex bias in elite control of paediatric HIV infection: Erratum.
    AIDS. 2019;33:1959.
    >> Share


  514. Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix): Erratum Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection: E
    AIDS. 2019;33:1957.
    >> Share

  515. GUILLE M, Rousset S, Bonneville F, Mengelle C, et al
    IL-7 immunotherapy for progressive multifocal leukoencephalopathy in a patient with already controlled HIV-1 infection on antiretroviral therapy.
    AIDS. 2019;33:1954-1956.
    >> Share

  516. HAMMERSCHLAG Y, Korman TM, Woolley IJ
    HIV presenting as AIDS in previously undiagnosed tourists in a low-prevalence setting.
    AIDS. 2019;33:1952-1954.
    >> Share

  517. FAUSTINO E, Fielding J, Teutsch S
    Eliminating the HIV epidemic: the US government can make preexposure prophylaxis affordable now.
    AIDS. 2019;33:1951-1952.
    >> Share

  518. STOPARD IJ, Hauck K, Hallett TB
    The influence of constraints on the efficient allocation of resources for HIV prevention: authors' response.
    AIDS. 2019;33:1950-1951.
    >> Share

  519. STUART RM, Kelly SL, Kerr CC, Martin-Hughes R, et al
    The influence of constraints on the efficient allocation of resources for HIV prevention.
    AIDS. 2019;33:1949-1950.
    >> Share

  520. BREW BJ, McArthur J
    Distinguishing cognitive impairment from HIV-associated neurocognitive disorder versus substance use?
    AIDS. 2019;33:1943-1944.
    >> Share

  521. KHANNA AS, Schneider JA, Collier N, Ozik J, et al
    A modeling framework to inform preexposure prophylaxis initiation and retention scale-up in the context of 'Getting to Zero' initiatives.
    AIDS. 2019;33:1911-1922.
    >> Share

  522. CASTRO FOF, Silva JM, Dorneles GP, Barros JBS, et al
    Distinct inflammatory profiles in HIV-infected individuals under antiretroviral therapy using cannabis, cocaine or cannabis plus cocaine.
    AIDS. 2019;33:1831-1842.
    >> Share

  523. SVIRIDOV D, Mukhamedova N, Makarov AA, Adzhubei A, et al
    Co-morbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality.
    AIDS. 2019 Oct 1. doi: 10.1097/QAD.0000000000002385.
    >> Share

    September 2019
  524. CHAKRABORTY A, Qato DM, Awadalla S, Hershow RC, et al
    Antiretroviral therapy adherence among treatment-naive HIV-infected patients: A retrospective cohort study.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002384.
    >> Share

  525. VAN DE WIJGERT JHHM, Gill AC, Chikandiwa A, Verwijs MC, et al
    Human papillomavirus infection and cervical dysplasia in HIV-positive women: potential role of the vaginal microbiota.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002381.
    >> Share

  526. KENDALL EA, Durovni B, Martinson NA, Cavalacante S, et al
    Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002380.
    >> Share

  527. BURNS JE, Stirrup OT, Dunn D, Runcie-Unger I, et al
    No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002379.
    >> Share

  528. GENEROSO M, Alvarez P, Kravietz A, Mwamzuka M, et al
    High soluble CD163 levels correlate with disease progression and inflammation in kenyan children with perinatal hiv-infection.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002378.
    >> Share

  529. MCHALE JV, Aviles MAR
    Brexit and UK citizens with HIV residing in Spain: A matter of public health.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002376.
    >> Share

  530. LAPADULA G, Bernasconi DP, Bai F, Foca E, et al
    Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances: Results from a randomized controlled trial.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002377.
    >> Share

  531. MARSH K, Eaton JW, Mahy M, Sabin K, et al
    Global, regional and country-level 90-90-90 estimates for 2018: assessing progress towards the 2020 target.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002355.
    >> Share

  532. COURLET P, Stader F, Guidi M, Saldanha SA, et al
    Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging patients enrolled in the Swiss HIV Cohort Study.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002372.
    >> Share

  533. VENKATESH KK, Farhad M, Fenton T, Moodley D, et al
    Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002367.
    >> Share

  534. MUPFUMI L, Moyo S, Shin SS, Wang Q, et al
    High Incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National ART programme between 2011 and 2015.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002363.
    >> Share

  535. YUAN N, Scherzer R, Tanriverdi K, Martin J, et al
    MicroRNA biomarkers associated with type 1 myocardial infarction in HIV positive individuals.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002368.
    >> Share

  536. OTIENO G, Whiteside YO, Achia T, Kwaro D, et al
    Decreased HIV-associated mortality rates during scale-up of antiretroviral therapy, 2011-2016: a population-based cohort study.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002374.
    >> Share

  537. FEITERNA-SPERLING C, Kruger R, Amara A, Khoo S, et al
    Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1 infected women.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002360.
    >> Share

  538. LAMPE FC, Rodger AJ, Burman W, Grulich A, et al
    Impact of early antiretroviral treatment on sexual behaviour in the INSIGHT Strategic Timing of Anti-Retroviral Treatment (START) Trial.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002359.
    >> Share

  539. KIM-CHANG JJ, Donovan K, Loop MS, Hong S, et al
    Higher soluble CD14 levels are associated with lower visuospatial memory performance in Youth with HIV (YWH).
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002371.
    >> Share

  540. CARLUCCI JG, Liu Y, Clouse K, Vermund SH, et al
    Attrition of HIV-positive children from HIV services in low- and middle-income countries: a systematic review and meta-analysis.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002366.
    >> Share

  541. NELSON JAE, de Paris K, Ramirez C, Edmonds A, et al
    Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002373.
    >> Share

  542. MAUGHAN-BROWN B, Venkataramani A, Kharsany AB, Beckett S, et al
    Recently formed age-disparate partnerships are associated with elevated HIV incidence among young women in South Africa.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002362.
    >> Share

  543. GRAS J, Mahjoub N, Charreau I, Cotte L, et al
    Early diagnosis and risk factors of acute hepatitis c in high-risk men who have sex with men on pre-exposure prophylaxis.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002364.
    >> Share

  544. SAINZ T, Serrano-Villar S, Mann S, Ma ZM, et al
    Delayed GALT reconstitution in duodenum compared to rectum in hiv-infected patients initiating antiretroviral therapy.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002361.
    >> Share

  545. JOSKA JA, Dreyer AJ, Nightingale S, Combrinck MI, et al
    Prevalence of HIV-1 Infection in an elderly rural population and associations with neurocognitive impairment.
    AIDS. 2019;33:1765-1771.
    >> Share

  546. KOUAMOU V, Manasa J, Katzenstein D, McGregor AM, et al
    Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy.
    AIDS. 2019;33:1729-1737.
    >> Share

  547. SHAHAR E, Shapiro A, Baskin L, Oz ZK, et al
    Antiretroviral therapy-induced negative HIV antibody test following diagnosis of HIV infection.
    AIDS. 2019;33:1804-1805.
    >> Share

  548. SUZUKI T, Uemura H, Yanagawa Y, Mizushima D, et al
    Successful treatment for Kaposi sarcoma inflammatory cytokine syndrome in a severe CD4+ lymphocytopenic HIV patient.
    AIDS. 2019;33:1801-1802.
    >> Share

  549. BREW BJ, Paul R
    HIV-associated neurocognitive disorder, extracellular vesicles and gender: vive la difference?
    AIDS. 2019;33:1795-1796.
    >> Share

    August 2019
  550. MILINKOVIC A, Berger F, Arenas-Pinto A, Mauss S, et al
    Lipid changes due to tenofovir alafenamide are reversible by switching back to tenofovir disoproxil fumarate.
    AIDS. 2019 Aug 29. doi: 10.1097/QAD.0000000000002350.
    >> Share

  551. MCHEMBERE W, Agaya J, Yuen CM, Okelloh D, et al
    High yield of new HIV diagnoses during active case-finding for tuberculosis.
    AIDS. 2019 Aug 22. doi: 10.1097/QAD.0000000000002354.
    >> Share

  552. DONALDSON MA, Campbell AR, Albert AY, Borhani M, et al
    Comorbidity and polypharmacy among women living with HIV in British Columbia.
    AIDS. 2019 Aug 22. doi: 10.1097/QAD.0000000000002353.
    >> Share

  553. KIDMAN R, Kohler HP
    Adverse childhood experiences, sexual debut and HIV testing among adolescents in a low-income high HIV-prevalence context.
    AIDS. 2019 Aug 22. doi: 10.1097/QAD.0000000000002352.
    >> Share

  554. THIN K, Frederix K, McCracken S, Letsie M, et al
    Progress toward HIV epidemic control in lesotho: results from a population-based survey.
    AIDS. 2019 Aug 22. doi: 10.1097/QAD.0000000000002351.
    >> Share

  555. PALELLA FJ JR, Hart R, Armon C, Tedaldi E, et al
    Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care.
    AIDS. 2019 Aug 22. doi: 10.1097/QAD.0000000000002349.
    >> Share

  556. ANDERSON AM, Perez-Santiago J, Zheng Z, Huang E, et al
    Better executive function is independently associated with full HIV suppression during combination therapy.
    AIDS. 2019 Aug 20. doi: 10.1097/QAD.0000000000002348.
    >> Share

  557. SCOTT HM, Spinelli M, Vittinghoff E, Morehead-Gee A, et al
    Racial/Ethnic and HIV risk category disparities in PrEP discontinuation among patients in publicly-funded primary care clinics.
    AIDS. 2019 Aug 20. doi: 10.1097/QAD.0000000000002347.
    >> Share

  558. MONTGOMERY ET, Roberts ST, Nel A, Malherbe M, et al
    Social Harms in Female-INITIATED hiv prevention method RESEARCH: state of the evidence.
    AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002346.
    >> Share

  559. COSTINIUK CT, Jenabian MA
    Cannabinoids and inflammation: Implications for People Living with HIV.
    AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002345.
    >> Share

  560. KREMER WW, Van Zummeren M, Breytenbach E, Richter KL, et al
    The use of molecular markers for cervical screening of women living with hiv in South Africa.
    AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002325.
    >> Share

  561. MAHIANE SG, Marsh K, Glaubius R, Eaton JW, et al
    Estimating and projecting the number of new HIV diagnoses and incidence in Spectrum's case surveillance and vital registration tool.
    AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002324.
    >> Share

  562. HENRIQUEZ S, Lecuroux C, Bitu M, Avettand-Fenoel V, et al
    The proportion of CD57+ cells among effector CD8+ T cells is lower HIV controllers compared to ART treated patients.
    AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002342.
    >> Share

  563. ROXBY AC, Yuhas K, Farquhar C, Bosire R, et al
    Mycoplasma genitalium infection among HIV-infected pregnant African women and implications for mother-to-child transmission of HIV.
    AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002335.
    >> Share

  564. RYOM L, Lundgren JD, Law M, Kirk O, et al
    Serious clinical events in HIV-positive persons with chronic kidney disease (CKD).
    AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002331.
    >> Share

  565. PALANEE-PHILLIPS T, Brown ER, Szydlo D, Matovu Kiweewa F, et al
    Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study.
    AIDS. 2019;33:1619-1622.
    >> Share

  566. FAURHOLT-JEPSEN D, Olsen MF, Andersen AB, Kaestel P, et al
    Hyperglycemia and insulin function in antiretroviral treatment-naive HIV patients in Ethiopia: a potential new entity of diabetes in HIV?
    AIDS. 2019;33:1595-1602.
    >> Share

  567. GROSSMAN MA, Hofmann C, Ng HL, Yang OO, et al
    Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones.
    AIDS. 2019;33:1565-1574.
    >> Share

  568. KEARNS AC, Velasquez S, Liu F, Dai S, et al
    Elevated indoleamine-2,3-dioxygenase enzyme activity in a novel mouse model of HIV-associated atherosclerosis.
    AIDS. 2019;33:1557-1564.
    >> Share

  569. CAPPELLETTI A, Peri AM, Bisi L, Sabbatini F, et al
    Recurrent posterior reversible encephalopathy syndrome in an HIV-HCV coinfected liver transplant recipient.
    AIDS. 2019;33:1679-1681.
    >> Share

  570. FLYNN PM, Abrams EJ
    Response to correspondence entitled: Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1675-1677.
    >> Share

  571. DAUBY N
    Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1674-1675.
    >> Share

  572. RIZZARDO S, Lanzafame M, Lattuada E, Luise D, et al
    Dolutegravir monotherapy and body weight gain in antiretroviral naive patients.
    AIDS. 2019;33:1673-1674.
    >> Share

  573. PANTAZIS N, Papastamopoulos V, Paparizos V, Metallidis S, et al
    Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy.
    AIDS. 2019;33:1645-1655.
    >> Share

  574. SHROUFI A, Van Cutsem G, Cambiano V, Bansi-Matharu L, et al
    Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure.
    AIDS. 2019;33:1635-1644.
    >> Share

  575. MORGELLO S, Gensler G, Sherman S, Ellis RJ, et al
    Frailty in medically complex individuals with chronic HIV.
    AIDS. 2019;33:1603-1611.
    >> Share

  576. RIZZARDINI G, Gori A, Miralles C, Olalla J, et al
    Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen.
    AIDS. 2019;33:1583-1593.
    >> Share

  577. UMLAUF A, Soontornniyomkij B, Sundermann EE, Gouaux B, et al
    Risk of developing cerebral beta-amyloid plaques with post-translational modification among HIV-infected adults.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002336.
    >> Share

  578. LE CN, Britto P, Brummel SS, Hoffman RM, et al
    Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared to men.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002334.
    >> Share

  579. REQUENA S, Caballero E, Lozano AB, Rios-Villegas MJ, et al
    Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002338.
    >> Share

  580. KNUDSEN AD, Kofoed KF, Gelpi M, Sigvardsen PE, et al
    Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002327.
    >> Share

  581. MEINCK F, Pantelic M, Spreckelsen TF, Orza L, et al
    Interventions to reduce gender-based violence among young people living with or affected by HIV/AIDS in low- and middle- income countries.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002337.
    >> Share

  582. FRENCH M
    Antibody-mediated control of HIV-1 infection through an alternative pathway.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002313.
    >> Share

    July 2019
  583. MAHY M, Marsh K, Sabin K, Wanyeki I, et al
    HIV estimates through 2018: data for decision making.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002321.
    >> Share

  584. MEYERS DJ, Cole MB, Rahman M, Lee Y, et al
    The association of provider and practice factors with HIV ART adherence.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002316.
    >> Share

  585. WANG Y, Brummel SS, Beilstein-Wedel E, Dagnall CL, et al
    Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birth.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002317.
    >> Share

  586. NEESGAARD B, Pelchen-Matthews A, Ryom L, Florence E, et al
    Uptake and effectiveness of two-drug compared to three-drug antiretroviral Regimens among HIV-positive Individuals in Europe.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002320.
    >> Share

  587. CEDARBAUM E, Ma Y, Scherzer R, Price JC, et al
    Contributions of HIV, HCV, and traditional vascular risk factors to peripheral artery disease in women.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002319.
    >> Share

  588. DE LAZZARI E, Lonca M, Rojas J, Gonzalez-Cordon A, et al
    A 24-week pilot study of dual maintenance therapy with raltegravir plus lamivudine.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002311.
    >> Share

  589. TRUONG HM, O'keefe KJ, Pipkin S, Liegler T, et al
    How are transgender women acquiring hiv? insights from phylogenetic transmission clusters in San Francisco.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002318.
    >> Share

  590. WANG Z, Molsberry SA, Cheng Y, Kingsley L, et al
    Cross-sectional analysis of cognitive function in the MACS with multivariate normative comparisons.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002312.
    >> Share

  591. RICHERT-SPUHLER LE, Pattacini L, Plews M, Irungu E, et al
    Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in HSV-2 seropositive women.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002323.
    >> Share


  592. Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission: Erratum.
    AIDS. 2019;33:1543.
    >> Share

  593. TENFORDE MW, Meintjes G, Mokomane M, Harrison TS, et al
    Low-cerebrospinal fluid white cell counts and mortality in HIV-associated pneumococcal meningitis.
    AIDS. 2019;33:1539-1541.
    >> Share

  594. XIA Q, Abraham B, Shah D, Ramaswamy C, et al
    Authors' reply, Xia et al.
    AIDS. 2019;33:1537-1539.
    >> Share

  595. KEMP CG, Lipira L, Huh D, Nevin PE, et al
    HIV stigma and viral load among African-American women receiving treatment for HIV.
    AIDS. 2019;33:1511-1519.
    >> Share

  596. CITERNE Q, Boyer L, Moreau E, Garon J, et al
    Cluster headache-like symptoms during treatment with tenofovir disoproxil fumarate and emtricitabine.
    AIDS. 2019;33:1535-1536.
    >> Share

  597. FLEMING J, Mathews WC, Rutstein RM, Aberg J, et al
    Low level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002306.
    >> Share

  598. DELL'ACQUA R, Galli L, Poli A, Mastrangelo A, et al
    Viro-immunological outcomes after thirteen-valent pneumococcal vaccination in HIV-1 infected subjects on stable virological suppression.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002307.
    >> Share

  599. PATEL RC, Stalter RM, Thomas KK, Tamraz B, et al
    A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002308.
    >> Share

  600. TEASDALE CA, Yuengling KA, Mutiti A, Arpadi S, et al
    Delays in fast track ART initiation and reasons for not starting treatment among eligible children in Eastern Cape, South Africa.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002309.
    >> Share

  601. DURIER C, Desaint C, Lelievre JD, Silbermann B, et al
    Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials: a French cohort study.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002310.
    >> Share

  602. THOMPSON-PAUL AM, Palella FJ Jr, Rayeed N, Ritchey MD, et al
    Excess heart age in adult outpatients in routine HIV care.
    AIDS. 2019 Jul 3. doi: 10.1097/QAD.0000000000002304.
    >> Share

  603. KACANEK D, Huo Y, Malee K, Mellins CA, et al
    Nonadherence and unsuppressed viral load across adolescence among US youth with perinatally acquired HIV.
    AIDS. 2019 Jul 3. doi: 10.1097/QAD.0000000000002301.
    >> Share

  604. POUDYAL D, Yang J, Chen Q, Goswami S, et al
    IL-27 posttranslationally regulates Y-box binding protein-1 to inhibit HIV-1 replication in human CD4+ T cells.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002288.
    >> Share

  605. SACKS JA, Fong Y, Gonzalez MP, Andreotti M, et al
    Performance of cepheid GeneXpert HIV-1 viral load plasma assay to accurately detect treatment failure: a clinical meta-analysis.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002303.
    >> Share

  606. BRENNAN AT, Berry KM, Rosen S, Stokes A, et al
    Growth curve modelling to determine distinct body mass index trajectory groups in HIV-positive adults on ART in South Africa.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002302.
    >> Share

  607. CHAGANTI J, Marripudi K, Staub LP, Rae CD, et al
    Imaging correlates of the Blood Brain Barrier disruption in HIV associated neurocognitive disorder and therapeutic implications.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002300.
    >> Share

  608. CRICHTON S, Belfrage E, Collins IJ, Doerholt K, et al
    Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002294.
    >> Share

  609. KHANNA AS, Schneider JA, Collier N, Ozik J, et al
    A modeling framework to inform PrEP initiation and retention scale-up in the context of Getting to Zero Initiatives.
    AIDS. 2019 Jul 2. doi: 10.1097/QAD.0000000000002290.
    >> Share

  610. VELEZ-DIAZ-PALLARES M
    Are we using the correct methods to measure efficacy in HIV trials?
    AIDS. 2019;33:1408-1409.
    >> Share

  611. TEN BRINK D, Martin-Hughes R, Kelly SL, Wilson DP, et al
    What is the impact of a 20% funding cut in international HIV aid from the United States?
    AIDS. 2019;33:1406-1408.
    >> Share

  612. MBAE M, Owen L, Elisha KK, Ndhere A, et al
    Excess early mortality in HIV/hepatitis B virus co-infected patients initiating antiretroviral therapy in Kenya.
    AIDS. 2019;33:1404-1406.
    >> Share

  613. KAY A, Moser C, McKhann A, Vargas M, et al
    Soluble suppression of tumorigenicity 2 levels are not predictive of non-AIDS events during antiretroviral therapy-mediated viral suppression.
    AIDS. 2019;33:1397-1399.
    >> Share

  614. SHARMA S, Schlusser KE, de la Torre P, Tambussi G, et al
    The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection.
    AIDS. 2019;33:1335-1344.
    >> Share

    June 2019
  615. DE FRANCESCO D, Underwood J, Bagkeris E, Anderson J, et al
    Risk factors and impact of patterns of co-occurring comorbidities in people living with HIV.
    AIDS. 2019 Jun 26. doi: 10.1097/QAD.0000000000002293.
    >> Share

  616. SPINELLI MA, Hessol NA, Schwarcz S, Hsu L, et al
    Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a U.S. City.
    AIDS. 2019 Jun 26. doi: 10.1097/QAD.0000000000002287.
    >> Share

  617. SENONER T, Barbieri F, Adukauskaite A, Sarcletti M, et al
    Coronary atherosclerosis characteristics in HIV infected patients on long term antiretroviral therapy: insights from coronary computed tomography angiography.
    AIDS. 2019 Jun 26. doi: 10.1097/QAD.0000000000002297.
    >> Share

  618. SPANO JP, Veyri M, Gobert A, Guihot A, et al
    Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience on behalf of the French CANCERVIH network.
    AIDS. 2019 Jun 26. doi: 10.1097/QAD.0000000000002298.
    >> Share

  619. MARTIN EM, Gonzalez R, Vassileva J, Bechara A, et al
    Double dissociation of HIV and substance use disorders effects on neurocognitive tasks dependent on striatal integrity.
    AIDS. 2019 Jun 26. doi: 10.1097/QAD.0000000000002291.
    >> Share

  620. RAYMOND S, Jeanne N, Nicot F, Lefebvre C, et al
    Long-term evolution of transmitted CXCR4-using HIV-1 under effective antiretroviral therapy.
    AIDS. 2019 Jun 26. doi: 10.1097/QAD.0000000000002295.
    >> Share

  621. CASTRO FOF, Silva JM, Dorneles GP, Barros JBS, et al
    Distinct inflammatory profiles in HIV-infected individuals under ART using cannabis, cocaine or cannabis plus cocaine.
    AIDS. 2019 Jun 26. doi: 10.1097/QAD.0000000000002296.
    >> Share

  622. WOJTOWICZ A, Bibert S, Taffe P, Bernasconi E, et al
    IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.
    AIDS. 2019 Jun 18. doi: 10.1097/QAD.0000000000002283.
    >> Share

  623. BEER L, Tie Y, Padilla M, Shouse RL, et al
    Generalized anxiety disorder symptoms among persons with diagnosed HIV in the United States-2015-2016, medical monitoring project.
    AIDS. 2019 Jun 17. doi: 10.1097/QAD.0000000000002286.
    >> Share

  624. RADFORD M, Parks DC, Ferrante S, Punekar Y, et al
    Dolutegravir and lamivudine vs other antiviral regimens in HIV-1 treatment-naive patients: a systematic review and network meta-analysis.
    AIDS. 2019 Jun 7. doi: 10.1097/QAD.0000000000002285.
    >> Share

  625. SABO MC, Richardson BA, Lavreys L, Martin HL Jr, et al
    Does bacterial vaginosis modify the effect of hormonal contraception on HIV seroconversion.
    AIDS. 2019;33:1225-1230.
    >> Share

  626. MCLELLAND CJ, Tseng AL, Walmsley SL, Chakrabarti S, et al
    Lymphocytic colitis in an HIV positive patient: is dolutegravir the cause?
    AIDS. 2019;33:1265-1266.
    >> Share

  627. LATINI A, Alei L, Covello R, Cristaudo A, et al
    Tonsillar Kaposi sarcoma in an HIV-negative patient.
    AIDS. 2019;33:1263-1264.
    >> Share

  628. ZILBER E, Martin GE, Willberg CB, Fox J, et al
    Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection.
    AIDS. 2019;33:1253-1256.
    >> Share

  629. FLICK RJ, Simon KR, Nyirenda R, Namachapa K, et al
    The HIV diagnostic assistant: early findings from a novel HIV testing cadre in Malawi.
    AIDS. 2019;33:1215-1224.
    >> Share

  630. KAPOOR N, Audsley J, Rupali P, Sasadeusz J, et al
    A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries.
    AIDS. 2019;33:1105-1115.
    >> Share

  631. VREEMAN RC, Nyandiko WM, Marete I, Mwangi A, et al
    Evaluating a patient-centred intervention to increase disclosure and promote resilience for children living with HIV in Kenya.
    AIDS. 2019;33 Suppl 1:S93-S101.
    >> Share

  632. HARRISON SE, Li X, Zhang J, Zhao J, et al
    A cluster randomized controlled trial to evaluate a resilience-based intervention for caregivers of HIV-affected children in China.
    AIDS. 2019;33 Suppl 1:S81-S91.
    >> Share

  633. KATZ IT, Bogart LM, Dietrich JJ, Leslie HH, et al
    Understanding the role of resilience resources, antiretroviral therapy initiation, and HIV-1 RNA suppression among people living with HIV in South Africa: a prospective cohort study.
    AIDS. 2019;33 Suppl 1:S71-S79.
    >> Share

  634. ZHAO Q, Mao Y, Li X, Qiao S, et al
    Psychosocial correlates of health-related quality of life among people living with HIV in China: the mediating role of resilience.
    AIDS. 2019;33 Suppl 1:S63-S70.
    >> Share

  635. HARPER GW, Wagner RL, Popoff E, Reisner SL, et al
    Psychological resilience among transfeminine adolescents and emerging adults living with HIV.
    AIDS. 2019;33 Suppl 1:S53-S62.
    >> Share

  636. BARNIGHAUSEN KE, Matse S, Kennedy CE, Lejeune CL, et al
    'This is mine, this is for me': preexposure prophylaxis as a source of resilience among women in Eswatini.
    AIDS. 2019;33 Suppl 1:S45-S52.
    >> Share

  637. QIAO S, Ingram L, Deal ML, Li X, et al
    Resilience resources among African American women living with HIV in Southern United States.
    AIDS. 2019;33 Suppl 1:S35-S44.
    >> Share

  638. KUO C, LoVette A, Pellowski J, Harrison A, et al
    Resilience and psychosocial outcomes among South African adolescents affected by HIV.
    AIDS. 2019;33 Suppl 1:S29-S34.
    >> Share

  639. MALEE KM, Kerr S, Paul R, Puthanakit T, et al
    Emotional and behavioral resilience among children with perinatally acquired HIV in Thailand and Cambodia.
    AIDS. 2019;33 Suppl 1:S17-S27.
    >> Share

  640. ROTHERAM-BORUS MJ, Christodoulou J, Hayati Rezvan P, Comulada WS, et al
    Maternal HIV does not affect resiliency among uninfected/HIV exposed South African children from birth to 5 years of age.
    AIDS. 2019;33 Suppl 1:S5-S16.
    >> Share

  641. HARRISON SE, Li X, Vermund SH
    From surviving to thriving: the role of resilience in meeting global HIV goals.
    AIDS. 2019;33 Suppl 1:S1-S4.
    >> Share

    May 2019
  642. MONTANO MA, Dombrowski JC, Dasgupta S, Golden MR, et al
    Differences in STI Risk comparing PrEP users and propensity score-matched historical controls in a clinic setting.
    AIDS. 2019 May 29. doi: 10.1097/QAD.0000000000002281.
    >> Share

  643. PAIM AC, Cummins NW, Natesampillai S, Garcia-Rivera E, et al
    HIV elite control is associated with reduced TRAILshort expression.
    AIDS. 2019 May 29. doi: 10.1097/QAD.0000000000002279.
    >> Share

  644. INZAULE SC, Mr J, Cournil A, Vitoria M, et al
    Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age: a double setback.
    AIDS. 2019 May 29. doi: 10.1097/QAD.0000000000002277.
    >> Share

  645. FASTENACKELS S, Sauce D, Vigouroux C, Avettand-Fenoel V, et al
    HIV mediated immune aging in young adults infected perinatally or during childhood.
    AIDS. 2019 May 29. doi: 10.1097/QAD.0000000000002275.
    >> Share

  646. STREHLAU R, Paximadis M, Patel F, Burke M, et al
    HIV diagnostic challenges in breast-fed infants of mothers on antiretroviral therapy.
    AIDS. 2019 May 29. doi: 10.1097/QAD.0000000000002276.
    >> Share

  647. SAMARANI S, Abulkhir A, Amre D, Mehraj V, et al
    The anti-inflammatory IL-37/SIGIRR axis is functionally compromised in HIV infection.
    AIDS. 2019 May 29. doi: 10.1097/QAD.0000000000002271.
    >> Share

  648. SUN B, Fernandes N, Pulliam L
    Profile of neuronal exosomes in HIV cognitive impairment exposes gender differences.
    AIDS. 2019 May 29. doi: 10.1097/QAD.0000000000002272.
    >> Share

  649. CHAN P, Ananworanich J
    Perspective on potential impact of HIV CNS latency on eradication.
    AIDS. 2019 May 13. doi: 10.1097/QAD.0000000000002264.
    >> Share

  650. SOVERSHAEVA E, Kranzer K, Mchugh G, Bandason T, et al
    History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children.
    AIDS. 2019 May 11. doi: 10.1097/QAD.0000000000002265.
    >> Share

  651. SLAVEN JE, Haas DW, Liu Z, Stein JH, et al
    GCH1 haplotypes and cardiovascular risk in HIV.
    AIDS. 2019 May 9. doi: 10.1097/QAD.0000000000002263.
    >> Share

  652. MEIRELES MV, Pascom ARP, Duarte EC, Mcfarland W, et al
    Comparative effectiveness of first-line antiretroviral therapy: results from a large real-world cohort after the implementation of Dolutegravir.
    AIDS. 2019 May 9. doi: 10.1097/QAD.0000000000002254.
    >> Share

  653. MORGELLO S, Gensler G, Sherman S, Ellis RJ, et al
    Frailty in the medically complex National NeuroAIDS Tissue Consortium (NNTC) cohort.
    AIDS. 2019 May 9. doi: 10.1097/QAD.0000000000002250.
    >> Share

  654. AMBROSIONI J, Rico JAF, Nicolas D, Mosquera MM, et al
    E157Q integrase strand-transfer inhibitor substitution in patients with acute/recent HIV infection.
    AIDS. 2019 May 6. doi: 10.1097/QAD.0000000000002243.
    >> Share

  655. SKERRITT L, Boileau NT
    Correspondence: behavioural changes following HIV seroconversion during the historical expansion of HIV treatment in the United States.
    AIDS. 2019;33:1102-1103.
    >> Share

  656. ASHARE RL, Thompson M, Leone F, Metzger D, et al
    Differences in the rate of nicotine metabolism among smokers with and without HIV.
    AIDS. 2019;33:1083-1088.
    >> Share

  657. MOYO S, Gaseitsiwe S, Zahralban-Steele M, Maruapula D, et al
    Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana.
    AIDS. 2019;33:1073-1082.
    >> Share

  658. THOMAS R, Friebel R, Barker K, Mwenge L, et al
    Work and home productivity of people living with HIV in Zambia and South Africa.
    AIDS. 2019;33:1063-1071.
    >> Share

  659. WHELTON SP, Deal JA, Zikusoka M, Jacobson LP, et al
    Associations between lipids and subclinical coronary atherosclerosis.
    AIDS. 2019;33:1053-1061.
    >> Share

  660. HUA S, Scott JM, Hanna DB, Haberlen SA, et al
    Plasma acylcarnitines and progression of carotid artery atherosclerosis in HIV infection.
    AIDS. 2019;33:1043-1052.
    >> Share

  661. ALBRECHT S, Franzeck FC, Mapesi H, Hatz C, et al
    Age-related comorbidities and mortality in people living with HIV in rural Tanzania.
    AIDS. 2019;33:1031-1041.
    >> Share

  662. WEBEL AR, Jenkins T, Vest M, Oliveira VHF, et al
    Cardiorespiratory fitness is associated with inflammation and physical activity in HIV+ adults.
    AIDS. 2019;33:1023-1030.
    >> Share

  663. KRONFLI N, Bhatnagar SR, Hull MW, Moodie EEM, et al
    Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up.
    AIDS. 2019;33:1013-1022.
    >> Share

  664. SESSA L, Reddel S, Manno E, Quagliariello A, et al
    Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.
    AIDS. 2019;33:1001-1011.
    >> Share

  665. LUPO J, Germi R, Lancar R, Algarte-Genin M, et al
    Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.
    AIDS. 2019;33:993-1000.
    >> Share

  666. COTE SC, Stilla A, Burke Schinkel SC, Berthoud TK, et al
    IL-7-induced proliferation of peripheral Th17 cells is impaired in HAART-controlled HIV infection.
    AIDS. 2019;33:985-991.
    >> Share

  667. KIM BH, Kelschenbach J, Borjabad A, Hadas E, et al
    Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice.
    AIDS. 2019;33:973-984.
    >> Share

  668. GUARDO AC, Zarama A, Gonzalez T, Bargallo ME, et al
    Effects on immune system and viral reservoir of a short-cycle antiretroviral therapy in virologically suppressed HIV-positive patients.
    AIDS. 2019;33:965-972.
    >> Share

  669. GORWOOD J, Bourgeois C, Mantecon M, Atlan M, et al
    Impact of HIV/simian immunodeficiency virus infection and viral proteins on adipose tissue fibrosis and adipogenesis.
    AIDS. 2019;33:953-964.
    >> Share

  670. MILNE RS, Silverman RA, Beck IA, Mckernan-Mullin J, et al
    Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women.
    AIDS. 2019;33:941-951.
    >> Share

  671. MONTOYA JL, Jankowski CM, O'Brien KK, Webel AR, et al
    Evidence-informed practical recommendations for increasing physical activity among persons living with HIV.
    AIDS. 2019;33:931-939.
    >> Share

  672. DEKKERS BGJ, Bierman WFW, Touw DJ, Alffenaar JC, et al
    Relevance of the drug-drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat.
    AIDS. 2019;33:1100-1102.
    >> Share

  673. JACOBS TG, Burger DM, Pranger AD, Khoo SH, et al
    Carbamazepine intervention in a patient with efavirenz-induced liver injury.
    AIDS. 2019;33:1097-1098.
    >> Share

  674. COHEN K, Viljoen C, Njuguna C, Maartens G, et al
    Emtricitabine-associated red cell aplasia.
    AIDS. 2019;33:1095-1096.
    >> Share

  675. BOYD SD, Sampson MR, Viswanathan P, Struble KA, et al
    Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint.
    AIDS. 2019;33:1089-1093.
    >> Share

    April 2019
  676. MURNANE PM, Bacchetti P, Currier JS, Brummel S, et al
    Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women.
    AIDS. 2019 Apr 22. doi: 10.1097/QAD.0000000000002237.
    >> Share

  677. KIM AA, Behel S, Northbrook S, Parekh BS, et al
    Tracking with recency assays to control the epidemic: real-time HIV surveillance and public health response.
    AIDS. 2019 Apr 22. doi: 10.1097/QAD.0000000000002239.
    >> Share

  678. XU J, Umlauf A, Letendre S, Franklin D, et al
    Catechol-O-methyltransferase polymorphism Val158Met is associated with distal neuropathic pain in HIV-associated sensory neuropathy.
    AIDS. 2019 Apr 22. doi: 10.1097/QAD.0000000000002240.
    >> Share

  679. VAN WELZEN BJ, Thielen MAJ, Mudrikova T, Arends JE, et al
    Switching tenofovir disoproxil fumarate to tenofovir alafenamide results in a significant decline in parathyroid hormone levels: uncovering the mechanism of tenofovir disoproxil fumarate-related bone loss?
    AIDS. 2019 Apr 22. doi: 10.1097/QAD.0000000000002238.
    >> Share

  680. O'HALLORAN JA, Cooley SA, Strain JF, Boerwinkle A, et al
    Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors.
    AIDS. 2019 Apr 16. doi: 10.1097/QAD.0000000000002236.
    >> Share

  681. BENZEKRI NA, Sambou JF, Ndong S, Tamba IT, et al
    Traditional healers, hiv outcomes, and mortality among people living with hiv in senegal, west africa.
    AIDS. 2019 Apr 16. doi: 10.1097/QAD.0000000000002232.
    >> Share

  682. CAI J, Osikowicz M, Sebastiani G
    Clinical significance of elevated liver transaminases in HIV-infected patients.
    AIDS. 2019 Apr 16. doi: 10.1097/QAD.0000000000002233.
    >> Share

  683. SHROUFI A, Van Cutsem G, Cambiano V, Bansi-Matharu L, et al
    Simplifying switch to second line ART: Predicted effect of defining failure of first-line efavirenz-based regimens in sub-Saharan Africa by a single viral load > 1000 copies/ml.
    AIDS. 2019 Apr 16. doi: 10.1097/QAD.0000000000002234.
    >> Share

  684. PRENDERGAST AJ, Berejena C, Pimundu G, Shonhai A, et al
    Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe.
    AIDS. 2019 Apr 16. doi: 10.1097/QAD.0000000000002231.
    >> Share

  685. SAMET JH, Blokhina E, Cheng DM, Walley AY, et al
    A strengths-based case management intervention to link HIV-positive PWID in Russia to HIV care - results from a randomized controlled trial.
    AIDS. 2019 Apr 5. doi: 10.1097/QAD.0000000000002230.
    >> Share

  686. KAY A, Moser C, McKhann A, Vargas M, et al
    sST2 levels are not predictive of Non-AIDS Events during Antiretroviral Therapy-mediated Viral Suppression.
    AIDS. 2019 Apr 3. doi: 10.1097/QAD.0000000000002228.
    >> Share

  687. REMIEN RH, Stirratt MJ, Nguyen N, Robbins RN, et al
    Mental health and HIV/AIDS: the need for an integrated response.
    AIDS. 2019 Apr 3. doi: 10.1097/QAD.0000000000002227.
    >> Share

  688. DAVEY DLJ, Bekker LG, Gomba Y, Coates T, et al
    Modelling the potential impact of providing pre-exposure prophylaxis (PrEP) in pregnant and breastfeeding women in South Africa.
    AIDS. 2019 Apr 3. doi: 10.1097/QAD.0000000000002221.
    >> Share

  689. ENNS B, Krebs E, Mathews WC, Moore RD, et al
    Heterogeneity in the costs of medical care among people living with HIV/AIDS in the United States.
    AIDS. 2019 Apr 3. doi: 10.1097/QAD.0000000000002220.
    >> Share

  690. JIN F, Vajdic CM, Law M, Amin J, et al
    Incidence and time trends of anal cancer among people living with HIV in Australia.
    AIDS. 2019 Apr 3. doi: 10.1097/QAD.0000000000002218.
    >> Share

  691. ALESSANDRI-GRADT E, Unal G, Leoz M, Plantier JC, et al
    Virological response to INSTI-based antiretroviral combinations in HIV-1 group O infected patients.
    AIDS. 2019 Apr 3. doi: 10.1097/QAD.0000000000002215.
    >> Share

  692. LAU JSY, Smith MZ, Lewin SR, McMahon JH, et al
    Clinical trials of antiretroviral treatment interruption in HIV-infected individuals.
    AIDS. 2019;33:773-791.
    >> Share

  693. WHOOLEY PD, Dorer RK, Kumar AS, Aboulafia DM, et al
    HIV-associated anorectal Epstein-Barr virus-positive mucocutaneous ulcer successfully treated with liposomal doxorubicin and rituximab.
    AIDS. 2019;33:929-930.
    >> Share

  694. KRUSI A
    Women incarceration and HIV: authors' reply.
    AIDS. 2019;33:927-929.
    >> Share

  695. NATHAN M
    Letter to the editor re: women, incarceration and HIV.
    AIDS. 2019;33:927.
    >> Share

  696. SANDERS EJ, Chirro O, Oduor C, Mangi J, et al
    Point-of-care HIV RNA testing and immediate antiretroviral therapy initiation in young adults seeking out-patient care in Kenya.
    AIDS. 2019;33:923-926.
    >> Share

  697. ZANNI MV, Grinspoon SK
    Striving to characterize endocrine-metabolic and immune health risks among transgender women with HIV.
    AIDS. 2019;33:919-922.
    >> Share

  698. OLDFIELD BJ, Munoz N, McGovern MP, Funaro M, et al
    Integration of care for HIV and opioid use disorder.
    AIDS. 2019;33:873-884.
    >> Share

  699. COFFEY S, Bacchetti P, Sachdev D, Bacon O, et al
    RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.
    AIDS. 2019;33:825-832.
    >> Share

  700. MAURICE JB, Garvey L, Tsochatzis EA, Wiltshire M, et al
    Monocyte-macrophage activation is associated with nonalcoholic fatty liver disease and liver fibrosis in HIV monoinfection independently of the gut microbiome and bacterial translocation.
    AIDS. 2019;33:805-814.
    >> Share

    March 2019
  701. BUCKEY JC, Fellows AM, Magohe A, Maro I, et al
    Hearing complaints in HIV infection originate in the brain not the ear.
    AIDS. 2019 Mar 29. doi: 10.1097/QAD.0000000000002229.
    >> Share

  702. LE ROUX SM, Abrams EJ, Nguyen KK, Myer L, et al
    HIV Incidence during breastfeeding and mother-to-child transmission in cape town, south africa.
    AIDS. 2019 Mar 29. doi: 10.1097/QAD.0000000000002224.
    >> Share

  703. SANTOSA WB, Staines-Urias E, Tshivuila-Matala COO, Norris SA, et al
    Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa.
    AIDS. 2019 Mar 29. doi: 10.1097/QAD.0000000000002222.
    >> Share

  704. SHARMA S, Schlusser KE, Torre P, Tambussi G, et al
    The benefit of immediate compared to deferred ART on CD4+ Cell count recovery in early HIV infection.
    AIDS. 2019 Mar 29. doi: 10.1097/QAD.0000000000002219.
    >> Share

  705. WILSON KS, Mugo C, Moraa H, Onyango A, et al
    Health provider training is associated with improved engagement in HIV care among adolescents and young adults in kenya.
    AIDS. 2019 Mar 29. doi: 10.1097/QAD.0000000000002217.
    >> Share

  706. KEMP CG, Lipira LL, Huh D, Nevin PE, et al
    HIV stigma and viral load among African-American women receiving treatment for HIV: A longitudinal analysis.
    AIDS. 2019 Mar 29. doi: 10.1097/QAD.0000000000002212.
    >> Share

  707. VIBHOLM LK, Konrad CV, Schleimann MH, Frattari G, et al
    Effects of 24 Week Toll-Like Receptor 9 Agonist Treatment in HIV-1+ Individuals: a single-arm, phase 1B/2A trial.
    AIDS. 2019 Mar 29. doi: 10.1097/QAD.0000000000002213.
    >> Share

  708. PINTYE J, Drake AL, Begnel E, Kinuthia J, et al
    Acceptability and outcomes of distributing HIV self-tests for male partner testing in Kenyan maternal child health and family planning clinics.
    AIDS. 2019 Mar 29. doi: 10.1097/QAD.0000000000002211.
    >> Share

  709. BANSI-MATHARU L, Loria GR, Cole SR, Mugerwa H, et al
    Risk factors for antiretroviral therapy (ART) discontinuation in a large multinational trial of early ART initiators.
    AIDS. 2019 Mar 29. doi: 10.1097/QAD.0000000000002210.
    >> Share

  710. KWON M, Bailen R, Balsalobre P, Jurado M, et al
    Allogeneic stem cell transplantation in HIV-1 infected patients with high-risk hematological disorders.
    AIDS. 2019 Mar 29. doi: 10.1097/QAD.0000000000002209.
    >> Share

  711. GUPTA SK, Post FA, Arribas JR, Jr JJE, et al
    Renal safety of tenofovir alafenamide vs tenofovir disoproxil fumarate: A pooled analysis of 26 clinical trials.
    AIDS. 2019 Mar 29. doi: 10.1097/QAD.0000000000002223.
    >> Share

  712. WEARNE N, Hung R, Bohmer R, Spies R, et al
    Kidney disease in africans with hiv and tuberculosis.
    AIDS. 2019 Mar 19. doi: 10.1097/QAD.0000000000002204.
    >> Share

  713. LI Y, Wang Z, Cheng Y, Becker JT, et al
    Neuropsychological changes in efavirenz switch regimens in the multicenter AIDS cohort study.
    AIDS. 2019 Mar 19. doi: 10.1097/QAD.0000000000002206.
    >> Share

  714. HUANG YS, Liu CE, Lin SP, Lee CH, et al
    Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia.
    AIDS. 2019 Mar 19. doi: 10.1097/QAD.0000000000002207.
    >> Share

  715. XU W, Pu J, Su S, Hua C, et al
    Revisiting the mechanism of enfuvirtide and designing an analog with improved fusion inhibitory activity by targeting triple sites in gp41.
    AIDS. 2019 Mar 19. doi: 10.1097/QAD.0000000000002208.
    >> Share

  716. KAEWPREEDEE P, Boonrat P, Tansiri Y, Rowland-Jones SL, et al
    Dimorphism in the T-cell receptor constant region affects T-cell function, phenotype and HIV outcome.
    AIDS. 2019 Mar 19. doi: 10.1097/QAD.0000000000002187.
    >> Share

  717. ZHANG WR, Scherzer R, Estrella MM, Ascher SB, et al
    Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women.
    AIDS. 2019;33:723-733.
    >> Share

  718. GARRIDO C, Tolstrup M, Sogaard OS, Rasmussen TA, et al
    In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV+ individuals.
    AIDS. 2019;33:605-613.
    >> Share


  719. Impact of aging and HIV infection on serologic response to seasonal influenza vaccination: Erratum.
    AIDS. 2019;33:771.
    >> Share


  720. Assessment of sarcopenia in virally suppressed HIV-infected Asians receiving treatment: Erratum.
    AIDS. 2019;33:769.
    >> Share


  721. Impact of glycemic status on longitudinal cognitive performance in men with and without HIV infection: Erratum.
    AIDS. 2019;33:767.
    >> Share

  722. DUSS FR, Moulin K, Moret Bochatay M, Bally F, et al
    Pneumococcal meningitis without pleocytosis in a patient infected with HIV-1.
    AIDS. 2019;33:765-766.
    >> Share

  723. AHMAD A, Samarani S, Kumar V
    Lipopolysaccharide-acylating capacity of the gut microbiota and its potential impact on the immunopathogenesis of HIV infection.
    AIDS. 2019;33:753-755.
    >> Share


  724. Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1.
    AIDS. 2019;33:745-751.
    >> Share

  725. BERENGUER J, Gil-Martin A, Jarrin I, Montes ML, et al
    Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals.
    AIDS. 2019;33:685-689.
    >> Share

  726. LING L, Wu T, To KKW, Cheung KW, et al
    Vedolizumab-mediated integrin alpha4beta7 blockade does not control HIV-1SF162 rebound after combination antiretroviral therapy interruption in humanized mice.
    AIDS. 2019;33:F1-F12.
    >> Share

  727. SIGEL KM, Stone K, Wisnivesky JP, Park LS, et al
    Short-term outcomes for lung cancer resection surgery in HIV infection.
    AIDS. 2019 Mar 15. doi: 10.1097/QAD.0000000000002200.
    >> Share

  728. REITSEMA M, Steffers L, Visser M, Heijne J, et al
    Cost-effectiveness of increased hiv testing among men who have sex with men in the netherlands.
    AIDS. 2019 Mar 15. doi: 10.1097/QAD.0000000000002199.
    >> Share

  729. LI QH, Shao B, Li J, Wang JY, et al
    Critical amino acid residues and potential N-linked glycosylation sites contribute to CRF01_AE pathogenesis in Northeast China.
    AIDS. 2019 Mar 13. doi: 10.1097/QAD.0000000000002197.
    >> Share

  730. CATTIN A, Salinas TRW, Gosselin A, Planas D, et al
    HIV-1 is rarely detected in blood and colon myeloid cells during viral-suppressive antiretroviral therapy.
    AIDS. 2019 Mar 11. doi: 10.1097/QAD.0000000000002195.
    >> Share

  731. CHEVALIER MF, Bhatnagar N, Didier C, Lopez-Gonzalez M, et al
    gammadelta T-cell subsets in HIV controllers: potential role of Tgammadelta17 cells in the regulation of chronic immune activation.
    AIDS. 2019 Mar 11. doi: 10.1097/QAD.0000000000002196.
    >> Share

  732. DAVY-MENDEZ T, Napravnik S, Zakharova O, Wohl DA, et al
    Effectiveness of integrase strand transfer inhibitors among treatment-experienced patients in a clinical setting.
    AIDS. 2019 Mar 11. doi: 10.1097/QAD.0000000000002194.
    >> Share

  733. LEDDY AM, Turan JM, Johnson MO, Neilands TB, et al
    Poverty stigma is associated with suboptimal HIV care and treatment outcomes among women living with HIV in the U.S.
    AIDS. 2019 Mar 11. doi: 10.1097/QAD.0000000000002189.
    >> Share

  734. PILCHER CD, Porco TC, Facente SN, Grebe E, et al
    A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results.
    AIDS. 2019 Mar 11. doi: 10.1097/QAD.0000000000002190.
    >> Share

  735. SALONER R, Heaton RK, Campbell LM, Chen A, et al
    Effects of comorbidity burden and Age on brain integrity in HIV.
    AIDS. 2019 Mar 11. doi: 10.1097/QAD.0000000000002192.
    >> Share

  736. CASTAGNA A, Rusconi S, Gulminetti R, Bonora S, et al
    Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy.
    AIDS. 2019 Mar 11. doi: 10.1097/QAD.0000000000002188.
    >> Share

  737. SANFORD R, Strain J, Dadar M, Maranzano J, et al
    HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment.
    AIDS. 2019 Mar 11. doi: 10.1097/QAD.0000000000002193.
    >> Share

  738. HONGE BL, Petersen MS, Jespersen S, Medina C, et al
    T and B-cell perturbations identify distinct differences in HIV-2 compared with HIV-1 induced immunodeficiency.
    AIDS. 2019 Mar 5. doi: 10.1097/QAD.0000000000002184.
    >> Share

  739. HONGE BL, Petersen MS, Jespersen S, Medina C, et al
    T and B-cell perturbations are similar in ART-naive HIV-1 and HIV-1/2 dually infected patients.
    AIDS. 2019 Mar 5. doi: 10.1097/QAD.0000000000002185.
    >> Share

  740. CORMA-GOMEZ A, Morano Amado L, Tellez F, Rivero-Juarez A, et al
    HIV infection does not impact on the risk of liver complications in HCV-infected patient with advanced fibrosis, after sustained virological response with DAA.
    AIDS. 2019 Mar 5. doi: 10.1097/QAD.0000000000002186.
    >> Share

  741. FLICK RJ, Simon KR, Nyirenda R, Namachapa K, et al
    The HIV diagnostic assistant-early findings from a novel HIV testing cadre in Malawi.
    AIDS. 2019 Mar 4. doi: 10.1097/QAD.0000000000002159.
    >> Share

  742. GIRARD A, Rallon N, Benito JM, Jospin F, et al
    A high mucosal blocking score is associated with HIV protection.
    AIDS. 2019;33:411-423.
    >> Share

  743. LAKE JE, Clark JL
    Optimizing HIV prevention and care for transgender adults.
    AIDS. 2019;33:363-375.
    >> Share

  744. NEL JS, Gay CL, Lachiewicz AM
    Further complexities in interpreting the serologic responses in HIV-negative recipients of HIV-positive organs.
    AIDS. 2019;33:595-596.
    >> Share

  745. GUERVENO C, Raymond S, Metsu D, Gandia P, et al
    HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy.
    AIDS. 2019;33:593-594.
    >> Share

  746. ZAUNDERS J
    Intersection of immune checkpoints and CD8+ T cell noncytolytic suppression of HIV-1 infection: putting on the brakes versus the nuclear option.
    AIDS. 2019;33:581-583.
    >> Share

  747. KOENIG LJ, O'Leary A
    Improving health outcomes for women with HIV: the potential impact of addressing internalized stigma and depression.
    AIDS. 2019;33:577-579.
    >> Share

  748. TURAN B, Rice WS, Crockett KB, Johnson M, et al
    Longitudinal association between internalized HIV stigma and antiretroviral therapy adherence for women living with HIV: the mediating role of depression.
    AIDS. 2019;33:571-576.
    >> Share

  749. TOMITA A, Vandormael A, Barnighausen T, Phillips A, et al
    Sociobehavioral and community predictors of unsuppressed HIV viral load: multilevel results from a hyperendemic rural South African population.
    AIDS. 2019;33:559-569.
    >> Share

  750. CONNOR RI, Zain-Ul-Abideen M, Magohe AK, Brickley EB, et al
    Sialic acid levels in breast milk from HIV-positive Tanzanian women and impact of maternal diet.
    AIDS. 2019;33:509-514.
    >> Share

  751. MACHIELS JD, Braam EE, van Bentum P, van Vugt M, et al
    Vaccination with Fendrix of prior nonresponding patients with HIV has a high success rate.
    AIDS. 2019;33:503-507.
    >> Share

  752. BELLAGAMBA R, Giancola ML, Tommasi C, Piselli P, et al
    Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment.
    AIDS. 2019;33:493-502.
    >> Share

  753. PEREZ-VALERO I, Ellis R, Heaton R, Deutsch R, et al
    Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.
    AIDS. 2019;33:475-481.
    >> Share

  754. CHRISTIAN B, Fabian E, Macha I, Mpangala S, et al
    Hepatitis B virus coinfection is associated with high early mortality in HIV-infected Tanzanians on antiretroviral therapy.
    AIDS. 2019;33:465-473.
    >> Share

  755. SHARMA A, Shi Q, Hoover DR, Tien PC, et al
    Frailty predicts fractures among women with and at-risk for HIV.
    AIDS. 2019;33:455-463.
    >> Share

  756. PANNUS P, Adams P, Willems E, Heyndrickx L, et al
    In-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8+ T cells in treated HIV-positive patients.
    AIDS. 2019;33:387-398.
    >> Share

    February 2019
  757. STIKSRUD B, Aass HCD, Lorvik KB, Ueland T, et al
    Activated dendritic cells and monocytes in HIV immunological non-responders; HIV-induced IP-10 correlates with low future CD4 recovery.
    AIDS. 2019 Feb 14. doi: 10.1097/QAD.0000000000002173.
    >> Share

  758. CHAN MK, Goodall R, Judd A, Klein N, et al
    Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand.
    AIDS. 2019 Feb 7. doi: 10.1097/QAD.0000000000002172.
    >> Share

  759. ALBRECHT S, Franzeck FC, Mapesi H, Hatz C, et al
    Age-related comorbidities and mortality in people living with HIV in rural Tanzania: data from a prospective cohort study.
    AIDS. 2019 Feb 7. doi: 10.1097/QAD.0000000000002171.
    >> Share

  760. MOYO S, Gaseitsiwe S, Zahralban-Steele M, Maruapula D, et al
    Low rates of NRTI and NNRTI drug resistance among participants in the Botswana combination prevention program (BCPP) trial.
    AIDS. 2019 Feb 7. doi: 10.1097/QAD.0000000000002166.
    >> Share

  761. FATUKASI TV, Edmonds A, Gustafson DR, Cole SR, et al
    Prevalence and 1-year incidence of frailty among women with and without HIV in the Women's Interagency HIV Study.
    AIDS. 2019;33:357-359.
    >> Share

  762. RAJASURIAR R, Palmer C, Abdel-Mohsen M, Kamaruzzaman SB, et al
    Integrative biomarkers of biologic aging in HIV.
    AIDS. 2019;33:345-347.
    >> Share


  763. Nucleoside reverse transcriptase inhibitor backbones and pregnancy outcomes.
    AIDS. 2019;33:295-304.
    >> Share

  764. MOSO MA, Anderson JL, Adikari S, Gray LR, et al
    HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal.
    AIDS. 2019;33:199-209.
    >> Share

  765. DE COCK KM, Barker JL, Baggaley R, El Sadr WM, et al
    Where are the positives? HIV testing in sub-Saharan Africa in the era of test and treat.
    AIDS. 2019;33:349-352.
    >> Share

  766. CUADROS DF, Li J, Mukandavire Z, Musuka GN, et al
    Towards UNAIDS Fast-Track goals: targeting priority geographic areas for HIV prevention and care in Zimbabwe.
    AIDS. 2019;33:305-314.
    >> Share

  767. MCGOWAN I, Wilkin T, Landovitz RJ, Wu C, et al
    The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM.
    AIDS. 2019;33:237-246.
    >> Share

    January 2019
  768. NASREDDINE R, de Wind R, De Wit S, Martin C, et al
    HIV virological failure in a patient with human T-lymphotropic virus type 1-associated leukemia.
    AIDS. 2019;33:159-160.
    >> Share

  769. DALOD M, Brooks A
    Broadening our knowledge of the differences between HIV-2 and HIV-1 innate sensing: HIV-2 infected cells selectively express B7-H6 and engage NKp30 on natural killer cells.
    AIDS. 2019;33:153-154.
    >> Share

  770. MONTOYA JL, Jankowski CM, O'Brien KK, Webel AR, et al
    Evidence-informed practical recommendations for increasing physical activity among persons living with HIV.
    AIDS. 2019 Jan 22. doi: 10.1097/QAD.0000000000002137.
    >> Share

  771. STUART RM, Haghparast-Bidgoli H, Panovska-Griffiths J, Grobicki L, et al
    Applying the 'no-one worse off' criterion to design Pareto efficient HIV responses in Sudan and Togo.
    AIDS. 2019 Jan 16. doi: 10.1097/QAD.0000000000002155.
    >> Share

  772. POMMIER JD, Laouenan C, Michard F, Papot E, et al
    Metabolic syndrome and endocrine status in HIV-infected transwomen.
    AIDS. 2019 Jan 16. doi: 10.1097/QAD.0000000000002152.
    >> Share

  773. WHELTON SP, Deal JA, Zikusoka M, Jacobson LP, et al
    Associations between lipids and subclinical coronary atherosclerosis.
    AIDS. 2019 Jan 16. doi: 10.1097/QAD.0000000000002151.
    >> Share

  774. MILNE RS, Silverman RA, Beck IA, Mckernan-Mullin J, et al
    Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI ART in Kenyan women.
    AIDS. 2019 Jan 16. doi: 10.1097/QAD.0000000000002134.
    >> Share

  775. STOPARD IJ, Mcgillen JB, Hauck K, Hallett TB, et al
    The influence of constraints on the efficient allocation of resources for HIV prevention: a modelling study.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002158.
    >> Share

  776. WEBEL AR, Jenkins T, Vest M, Oliveria VHF, et al
    Cardiorespiratory fitness is associated with inflammation and physical activity in HIV+ adults.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002154.
    >> Share

  777. LING L, Wu T, To KKW, Cheung KW, et al
    Vedolizumab-mediated integrin alpha4beta7 blockade does not control HIV-1SF162 rebound after cART interruption in humanized mice.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002149.
    >> Share

  778. SESSA L, Reddel S, Manno E, Quagliariello A, et al
    Distinct gut microbiota profile in ART-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002131.
    >> Share

  779. HUA S, Scott JM, Hanna DB, Haberlen SA, et al
    Plasma acylcarnitines and progression of carotid artery atherosclerosis in HIV infection.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002142.
    >> Share

  780. ASHARE RL, Thompson M, Leone F, Metzger D, et al
    Differences in the rate of nicotine metabolism among smokers with and without HIV.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002127.
    >> Share

  781. PHILLIPS NJ, Thomas KGF, Myer L, Sacktor N, et al
    Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: y-IHDS validation.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002144.
    >> Share

  782. TATE JP, Sterne JAC, Justice AC
    Improved discrimination of mortality with Veterans Aging Cohort Study (VACS) Index 2.0 in HIV-positive individuals.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002140.
    >> Share

  783. CHAISSON LH, Semitala FC, Asege L, Mwebe S, et al
    Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002130.
    >> Share

  784. DIRAJLAL-FARGO S, Mussi-Pinhata MM, Weinberg A, Yu Q, et al
    HIV-exposed uninfected infants have increased inflammation and monocyte activation.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002128.
    >> Share

  785. LUPO J, Germi R, Lancar R, Algarte-Genin M, et al
    Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern cART era.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002129.
    >> Share

  786. MAURICE JB, Garvey L, Tsochatzis EA, Wiltshire M, et al
    Monocyte-Macrophage activation is associated with NAFLD and liver fibrosis in HIV mono-infection independently of the gut microbiome and bacterial translocation.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002133.
    >> Share

  787. HOOTS BE, Wejnert C, Martin A, Haaland R, et al
    Undisclosed HIV infection among men who have sex with men in National HIV Behavioral Surveillance, 2014.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002147.
    >> Share

  788. COOK RR, Fulcher JA, Tobin NH, Li F, et al
    Effects of HIV viremia on the gastrointestinal microbiome of young men who have sex with men.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002132.
    >> Share

  789. NEWSUM AM, Kooij KW, Boyd A, Smit C, et al
    Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002138.
    >> Share

  790. BRITTAIN K, Phillips TK, Zerbe A, Abrams EJ, et al
    Long-term effects of unintended pregnancy on antiretroviral therapy outcomes among South African women living with HIV.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002139.
    >> Share

  791. KIM BH, Kelschenbach J, Borjabad A, Hadas E, et al
    Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HAND in EcoHIV-infected mice.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002150.
    >> Share

  792. KRONFLI N, Bhatnagar SR, Hull MW, Moodie EEM, et al
    Trends in cause-specific mortality in HIV-Hepatitis C co-infection following hepatitis C treatment scale-up.
    AIDS. 2019 Jan 12. doi: 10.1097/QAD.0000000000002156.
    >> Share

  793. D'ETTORRE G, Borrazzo C, Pinacchio C, Santinelli L, et al
    Increased IL-17 and/or IFN-gamma producing T cell subsets in gut mucosa of long-term treated HIV-1-infected women.
    AIDS. 2019 Jan 2. doi: 10.1097/QAD.0000000000002122.
    >> Share

  794. BERTERO L, Joseph SB, Trunfio M, Allice T, et al
    HIV-1 detection in the olfactory mucosa of HIV-1 infected participants.
    AIDS. 2019 Jan 2. doi: 10.1097/QAD.0000000000002102.
    >> Share

    December 2018
  795. HARPER KN
    Combination antibody treatment controls HIV infection in phase 1 trial.
    AIDS. 2018 Dec 21. doi: 10.1097/QAD.0000000000002117.
    >> Share

  796. HARPER KN
    HIV-associated cardiovascular disease is global scourge.
    AIDS. 2018 Dec 21. doi: 10.1097/QAD.0000000000002120.
    >> Share

  797. COFFEY S, Bacchetti P, Sachdev D, Bacon O, et al
    RAPID ART: High virologic suppression rates with immediate ART initiation in a vulnerable urban clinic population.
    AIDS. 2018 Dec 21. doi: 10.1097/QAD.0000000000002124.
    >> Share

  798. HEFFRON R, Stalter R, Pyra M, Nanda K, et al
    HIV risk associated with serum medroxyprogesterone acetate (MPA) levels among women in East and southern Africa: a case-control study.
    AIDS. 2018 Dec 21. doi: 10.1097/QAD.0000000000002123.
    >> Share

  799. GELPI M, Afzal S, Fuchs A, Lundgren J, et al
    Prior exposure to thymidine analogues and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors.
    AIDS. 2018 Dec 21. doi: 10.1097/QAD.0000000000002119.
    >> Share

  800. TODESCO E, Wirden M, Calin R, Simon A, et al
    Caution is needed in interpreting HIV transmission chains by ultra-deep sequencing.
    AIDS. 2018 Dec 21. doi: 10.1097/QAD.0000000000002105.
    >> Share

  801. BERENGUER J, Gil-Martin A, Jarrin I, Montes ML, et al
    Reinfection by HCV following effective all-oral DAA therapy in HIV/HCV-coinfected individuals.
    AIDS. 2018 Dec 21. doi: 10.1097/QAD.0000000000002103.
    >> Share

  802. OLDFIELD BJ, Munoz N, Mcgovern MP, Funaro M, et al
    Integration of care for HIV and opioid use disorder: a systematic review of interventions in clinical and community-based settings.
    AIDS. 2018 Dec 21. doi: 10.1097/QAD.0000000000002125.
    >> Share

  803. CREPAZ N, Hess KL, Purcell DW, Hall HI, et al
    Estimating national rates of HIV infection among men who have sex with men, persons who inject drugs and heterosexuals in the United States.
    AIDS. 2018 Dec 21. doi: 10.1097/QAD.0000000000002111.
    >> Share

  804. MACDONALD DM, Zanotto AD, Collins G, Baker JV, et al
    Associations between baseline biomarkers and lung function in HIV-positive individuals.
    AIDS. 2018 Dec 19. doi: 10.1097/QAD.0000000000002101.
    >> Share

  805. GUHA D, Mukerji SS, Chettimada S, Misra V, et al
    CSF extracellular vesicles and neurofilament light protein as biomarkers of CNS injury in HIV-infected patients on antiretroviral therapy.
    AIDS. 2018 Dec 14. doi: 10.1097/QAD.0000000000002121.
    >> Share

  806. TOMITA A, Vandormael A, Barnighausen T, Phillips A, et al
    Socio-behavioural and community predictors of unsuppressed viral load: multi-level results from a hyper-endemic rural South African population.
    AIDS. 2018 Dec 14. doi: 10.1097/QAD.0000000000002100.
    >> Share

  807. MCGOWAN I, Wilkin T, Landovitz RJ, Wu C, et al
    The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing PrEP Regimens in Men who have Sex with Men.
    AIDS. 2018 Dec 13. doi: 10.1097/QAD.0000000000002038.
    >> Share

  808. RHEAD R, Skovdal M, Takaruza A, Maswera R, et al
    The multidimensionality of masculine norms in east Zimbabwe: implications for HIV prevention, testing and treatment.
    AIDS. 2018 Dec 10. doi: 10.1097/QAD.0000000000002041.
    >> Share

    November 2018

  809. Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infection: Erratum.
    AIDS. 2018;32:2857-2858.
    >> Share

  810. SLOGROVE AL, Powis KM, Bettinger JA, Cotton MF, et al
    Considerations in evaluating infectious morbidity and mortality in HIV-exposed uninfected infants.
    AIDS. 2018;32:2855-2856.
    >> Share

  811. GUNST JD
    New insight into the mechanisms of achieving antiretroviral therapy-free HIV-1 control.
    AIDS. 2018;32:2839-2840.
    >> Share

  812. NYANHETE T, Tomaras GD
    CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control.
    AIDS. 2018;32:2835-2838.
    >> Share


  813. Non-Hodgkin lymphoma risk in adults living with HIV across five continents.
    AIDS. 2018;32:2777-2786.
    >> Share

  814. SUNDERMANN EE, Heaton RK, Pasipanodya E, Moore RC, et al
    Sex differences in HIV-associated cognitive impairment.
    AIDS. 2018;32:2719-2726.
    >> Share

  815. CHEN JS, Pence BW, Rahangdale L, Patterson KB, et al
    Postpartum HIV care continuum outcomes in the Southeastern US.
    AIDS. 2018 Nov 27. doi: 10.1097/QAD.0000000000002094.
    >> Share

  816. MORGAN E, Taylor HE, Ryan DT, D'Aquila R, et al
    Systemic inflammation is elevated among both HIV-uninfected and -infected young men who have sex with men.
    AIDS. 2018 Nov 27. doi: 10.1097/QAD.0000000000002093.
    >> Share

  817. FLYNN PM, Abrams EJ
    Growing up with perinatal HIV.
    AIDS. 2018 Nov 27. doi: 10.1097/QAD.0000000000002092.
    >> Share

  818. TRUNFIO M, Pinnetti C, Foca E, Bai F, et al
    Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?
    AIDS. 2018 Nov 27. doi: 10.1097/QAD.0000000000002091.
    >> Share

  819. DE AZEVEDO SSD, Delatorre E, Cortes FH, Hoagland B, et al
    HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection.
    AIDS. 2018 Nov 27. doi: 10.1097/QAD.0000000000002090.
    >> Share

  820. STORM-LARSEN C, Stiksrud B, Eriksen C, Nowak P, et al
    Microbial translocation revisited: targeting the endotoxic potential of gut microbes in HIV-infected individuals.
    AIDS. 2018 Nov 27. doi: 10.1097/QAD.0000000000002087.
    >> Share

  821. MORON-LOPEZ S, Kim P, SoGaard OS, Tolstrup M, et al
    Characterization of the HIV-1 transcription profile after romidepsin administration in ART-suppressed individuals.
    AIDS. 2018 Nov 27. doi: 10.1097/QAD.0000000000002083.
    >> Share

  822. KING EM, Albert AY, Murray MCM
    HIV and amenorrhea: A meta-analysis.
    AIDS. 2018 Nov 27. doi: 10.1097/QAD.0000000000002084.
    >> Share

  823. CYSIQUE LA, Juge L, Lennon MJ, Gates TM, et al
    HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection.
    AIDS. 2018 Nov 19. doi: 10.1097/QAD.0000000000002076.
    >> Share

  824. HILL KJ, Rogers LC, Njenda DT, Burke DH, et al
    Strain-specific effect on biphasic DNA binding by HIV-1 integrase.
    AIDS. 2018 Nov 19. doi: 10.1097/QAD.0000000000002078.
    >> Share

  825. TIBUAKUU M, Fashanu OE, Zhao D, Otvos JD, et al
    GlycA, a novel inflammatory marker, is associated with subclinical coronary disease in the multicenter AIDS cohort study.
    AIDS. 2018 Nov 19. doi: 10.1097/QAD.0000000000002079.
    >> Share

  826. GNANASHANMUGAM D, Rakhmanina N, Crawford K, Nesheim S, et al
    Eliminating perinatal HIV in the United States: mission possible?
    AIDS. 2018 Nov 19. doi: 10.1097/QAD.0000000000002080.
    >> Share

  827. STEEN R, Hontelez JAC, Mugurungi O, Mpofu A, et al
    Economy, migrant labour and sex work - interplay of HIV epidemic drivers in Zimbabwe over three decades.
    AIDS. 2018 Nov 19. doi: 10.1097/QAD.0000000000002066.
    >> Share

  828. LOAREC A, Carnimeo V, Molfino L, Kizito W, et al
    Extremely Low Hepatitis C prevalence among HIV co-infected individuals in 4 countries in sub-Saharan Africa.
    AIDS. 2018 Nov 16. doi: 10.1097/QAD.0000000000002070.
    >> Share


  829. Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals: Erratum.
    AIDS. 2018;32:2649.
    >> Share


  830. Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1: Erratum.
    AIDS. 2018;32:2643-2647.
    >> Share

  831. NHEAN S, Bravo J, Sheehan NL, Walmsley S, et al
    Successful use of the potent enzyme inducer enzalutamide in a treatment-experienced HIV-positive male with prostate cancer.
    AIDS. 2018;32:2640-2642.
    >> Share

  832. TARTAGLIA A
    Multidrug nanosuspensions: future perspectives on drug delivery system for HIV combination antiretroviral therapy.
    AIDS. 2018;32:2629-2631.
    >> Share

  833. ROZHNOVA G, Heijne J, Bezemer D, van Sighem A, et al
    Elimination prospects of the Dutch HIV epidemic among men who have sex with men in the era of preexposure prophylaxis.
    AIDS. 2018;32:2615-2623.
    >> Share

  834. WANG R, Haberlen SA, Palella FJ Jr, Mugavero MJ, et al
    Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough?
    AIDS. 2018;32:2547-2556.
    >> Share

    October 2018
  835. MOLINA-LEYVA A, Badiola J
    Severe refractory hidradenitis suppurativa successfully treated with adalimumab in an HIV-positive/hepatitis C virus-positive patient.
    AIDS. 2018;32:2436-2438.
    >> Share

  836. GAILLET A, Calin R, Imbert S, Ollivier M, et al
    Distinct paradoxical inflammatory reaction followed by postantiretroviral therapy immune reconstitution syndrome in cryptococcal meningitis.
    AIDS. 2018;32:2434-2436.
    >> Share

  837. SCHIM VAN DER LOEFF MF
    Secondary anal cancer prevention in the HIV-infected: a step ahead but a long way to go.
    AIDS. 2018;32:2425-2427.
    >> Share

  838. ROCKSTROH JK, Gonzalez-Scarano F
    Living donor liver transplant from an HIV-positive individual to an HIV-negative individual: could this become a new reality?
    AIDS. 2018;32:2423-2424.
    >> Share

  839. BOTHA J, Conradie F, Etheredge H, Fabian J, et al
    Living donor liver transplant from an HIV-positive mother to her HIV-negative child: opening up new therapeutic options.
    AIDS. 2018;32:F13-F19.
    >> Share

  840. DE FRANCESCO D, Wit FW, Burkle A, Oehlke S, et al
    Do people living with HIV experience greater age advancement than their HIV-negative counterparts?
    AIDS. 2018 Oct 16. doi: 10.1097/QAD.0000000000002063.
    >> Share

  841. ALDERSLEY J, Lorenz DR, Misra V, Uno H, et al
    Increased risk of anal squamous cell carcinoma in HIV-positive men with prior HBV infection.
    AIDS. 2018 Oct 16. doi: 10.1097/QAD.0000000000002059.
    >> Share

  842. MERCHANTE N, Figueruela B, Rodriguez-Fernandez M, Rodriguez-Arrondo F, et al
    Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients.
    AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002065.
    >> Share

  843. LUCAR O, Sadjo Diallo M, Bayard C, Samri A, et al
    B7-H6-mediated down-regulation of NKp30 in natural killer cells contributes to HIV-2 immune escape.
    AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002061.
    >> Share

  844. SRINIVASA S, Fitch KV, Torriani M, Zanni MV, et al
    Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV.
    AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002060.
    >> Share

  845. PALICH R, Ghosn J, Chaillon A, Boilet V, et al
    Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.
    AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002058.
    >> Share

  846. FAHEY CA, Njau PF, Dow WH, Kapologwe N, et al
    Effects of short-term cash and food incentives on food insecurity and nutrition among HIV-infected adults in Tanzania: a randomized trial.
    AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002056.
    >> Share